10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                       to                    .

Commission File Number:  0-8707

NATURE’S SUNSHINE PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

Utah	87-0327982
(State or other jurisdiction of	(IRS Employer
incorporation or organization)	Identification No.)

2500 West Executive Parkway, Suite 100

Lehi, Utah 84043

(Address of principal executive offices and zip code)

(801) 341-7900

(Registrant’s telephone number including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one).

Large accelerated filer o	Accelerated filer x
Non-accelerated filer o	Smaller reporting company o
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o No x.

The number of shares of Common Stock, no par value, outstanding on October 31, 2012 was 15,763,560 shares.

NATURE’S SUNSHINE PRODUCTS, INC.

FORM 10-Q

For the Quarter Ended September 30, 2012

Table of Contents

Part I. Financial Information
	Item 1.	Financial Statements (Unaudited)	3
		Condensed Consolidated Balance Sheets	3
		Condensed Consolidated Statements of Operations	4
		Condensed Consolidated Statements of Comprehensive Income	4
		Condensed Consolidated Statements of Cash Flows	6
		Notes to Condensed Consolidated Financial Statements	7
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	31
	Item 4.	Controls and Procedures	34
Part II. Other Information
	Item 1.	Legal Proceedings	35
	Item 1A.	Risk Factors	35
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
	Item 3.	Defaults Upon Senior Securities	35
	Item 4.	Mine Safety Disclosures	35
	Item 5.	Other Information	35
	Item 6.	Exhibits	36

2

PART I FINANCIAL INFORMATION

Item 1.  FINANCIAL STATEMENTS

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands)

(Unaudited)

	September 30, 2012			December 31, 2011
Assets
Current Assets:
Cash and cash equivalents	$	72,543		$	58,969
Accounts receivable, net of allowance for doubtful accounts of $607 and $647, respectively	10,003			9,868
Investments available for sale	2,192			5,677
Inventories	43,655			41,611
Deferred income tax assets	4,668			4,395
Prepaid expenses and other	5,946			4,583
Total current assets	139,007			125,103
Property, plant and equipment, net	27,975			25,137
Investment securities	1,317			1,429
Intangible assets, net	1,040			1,151
Deferred income tax assets	16,610			16,576
Other assets	6,619			6,415
	$	192,568		$	175,811
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts payable	$	5,710		$	5,980
Accrued volume incentives	19,802			19,326
Accrued liabilities	27,224			27,938
Deferred revenue	3,005			2,603
Current installments of long-term debt	3,334			3,296
Income taxes payable	4,468			8,655
Total current liabilities	63,543			67,798
Liability related to unrecognized tax benefits	9,772			10,426
Long-term debt	3,392			5,894
Deferred compensation payable	1,317			1,429
Other liabilities	2,696			2,826
Total long-term liabilities	17,177			20,575
Commitments and Contingencies (Note 10)
Shareholders’ Equity:
Common stock, no par value; 50,000 shares authorized, 15,761 and 15,569 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively	75,612			71,628
Retained earnings	45,203			25,879
Accumulated other comprehensive loss	(8,967		)	(10,069		)
Total shareholders’ equity	111,848			87,438
	$	192,568		$	175,811

See accompanying notes to the unaudited condensed consolidated financial statements.

3

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share information)

(Unaudited)

	Three Months Ended September 30,
	2012			2011
Net sales revenue (net of the rebate portion of volume incentives of $10,460 and $10,877, respectively)	$	91,232		$	91,102
Cost and expenses:
Cost of goods sold	17,713			16,879
Volume incentives	33,155			32,733
Selling, general and administrative	31,659			31,845
Contract termination costs	—			14,750
	82,527			96,207
Operating income (loss)	8,705			(5,105		)
Other income (expense), net	(214		)	1,204
Income (loss) before provision for income taxes	8,491			(3,901		)
Provision (benefit) for income taxes	2,121			(1,645		)
Net income (loss)	$	6,370		$	(2,256	)
Basic and diluted net income per common share
Basic:
Net income (loss) per common share	$	0.41		$	(0.14	)
Diluted:
Net income (loss) per common share	$	0.40		$	(0.14	)
Weighted average basic common shares outstanding	15,628			15,562
Weighted average diluted common shares outstanding	15,971			15,562
Dividends declared per common share	$	0.05		$	—

See accompanying notes to the unaudited condensed consolidated financial statements.

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Amounts in thousands)

(Unaudited)

	Three Months Ended September 30,
	2012		2011
Net income (loss)	$	6,370	$	(2,256	)
Foreign currency translation gain (loss) (net of tax)	1,416		(1,734		)
Net unrealized gains (losses) on investment securities (net of tax)	20		(40		)
Total comprehensive income (loss)	$	7,806	$	(4,030	)

See accompanying notes to the unaudited condensed consolidated financial statements.

4

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share information)

(Unaudited)

	Nine Months Ended September 30,
	2012			2011
Net sales revenue (net of the rebate portion of volume incentives of $32,746 and $33,815, respectively)	$	277,091		$	275,757
Cost and expenses:
Cost of goods sold	53,159			52,560
Volume incentives	100,276			100,421
Selling, general and administrative	95,466			97,458
Contract termination costs	—			14,750
	248,901			265,189
Operating income	28,190			10,568
Other income (expense), net	(159		)	1,049
Income before provision for income taxes	28,031			11,617
Provision for income taxes	7,147			1,637
Net income	20,884			9,980
Basic and diluted net income per common share
Basic:
Net income per common share	$	1.34		$	0.64
Diluted:
Net income per common share	$	1.31		$	0.64
Weighted average basic common shares outstanding	15,603			15,544
Weighted average diluted common shares outstanding	15,917			15,674
Dividends declared per common share	$	0.10		$	—

See accompanying notes to the unaudited condensed consolidated financial statements.

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Amounts in thousands)

(Unaudited)

	Nine Months Ended September 30,
	2012		2011
Net income	$	20,884	$	9,980
Foreign currency translation gain (loss) (net of tax)	1,061		(249		)
Net unrealized gains (loss) on investment securities (net of tax)	41		(18		)
Total comprehensive income	$	21,986	$	9,713

See accompanying notes to the unaudited condensed consolidated financial statements.

5

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(Unaudited)

	Nine Months Ended September 30,
	2012			2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	20,884		$	9,980
Adjustments to reconcile net income to net cash provided by (used in) by operating activities:
Provision for doubtful accounts	39			(101		)
Depreciation and amortization	3,028			3,204
Share-based compensation expense	2,001			1,917
Loss on sale of property and equipment	23			14
Deferred income taxes	(307		)	(4,419		)
Amortization of bond discount	3			13
Purchase of trading investment securities	(60		)	(59		)
Proceeds from sale of trading investment securities	268			338
Realized and unrealized (gains) losses on investments	(63		)	25
Foreign exchange losses	856			106
Changes in assets and liabilities:
Accounts receivable	(429		)	(5,691		)
Inventories	(1,926		)	(2,313		)
Prepaid expenses and other current assets	(1,021		)	607
Other assets	(148		)	(2,155		)
Accounts payable	(361		)	428
Accrued volume incentives	386			1,224
Accrued liabilities	(1,264		)	(4,554		)
Deferred revenue	403			(343		)
Income taxes payable	(4,222		)	848
Liability related to unrecognized tax benefits	(654		)	(2,834		)
Deferred compensation payable	(112		)	(355		)
Net cash provided by (used in) operating activities	17,324			(4,120		)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(5,617		)	(1,117		)
Proceeds from sale of property, plant and equipment	25			—
Proceeds from maturity and sale of investments available for sale	3,689			5,650
Purchase of investments available for sale	(197		)	(3,867		)
Net cash provided by (used in) investing activities	(2,100		)	666
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of long-term debt	—			10,000
Principal payments of long-term debt	(2,465		)	—
Dividends paid	(1,560		)	—
Proceeds from the exercise of stock options	1,982			372
Net cash provided by (used in) financing activities	(2,043		)	10,372
Effect of exchange rates on cash and cash equivalents	393			(419		)
Net increase in cash and cash equivalents	13,574			6,499
Cash and cash equivalents at the beginning of the period	58,969			47,604
Cash and cash equivalents at the end of the period	$	72,543		$	54,103
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes	$	12,694		$	7,851
Cash paid for interest	97			—

See accompanying notes to the unaudited condensed consolidated financial statements.

6

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in thousands, except per-share information)

(Unaudited)

(1)Basis of Presentation

Nature’s Sunshine Products, Inc., together with its subsidiaries (hereinafter referred to collectively as the “Company”), is a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. The Company is a Utah corporation with its principal place of business in Lehi, Utah, and sells its products to a sales force of independent Managers, Distributors and customers who use the products themselves or resell them to other Distributors or customers. The formulation, manufacturing, packaging, labeling, advertising, distribution and sale of each of the Company’s major product groups are subject to regulation by one or more governmental agencies.

The Company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, Indonesia, Ireland, Japan, Kazakhstan, Latvia, Lithuania, Malaysia, Mexico, Moldova, Mongolia, the Netherlands, Nicaragua, Norway, Panama, Peru, the Philippines, Poland, Russia, Singapore, South Korea, Spain, Sweden, Taiwan, Thailand, the Ukraine, the United Kingdom, the United States, Venezuela and Vietnam. The Company also exports its products to several other countries, including Argentina, Australia, Chile, Israel and New Zealand.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries.  All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial information as of September 30, 2012, and for the three month and nine month periods ended September 30, 2012 and 2011.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year ending December 31, 2012.

It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Classification of Belarus as a Highly Inflationary Economy and Devaluation of Its Currency

As of June 30, 2012, Belarus was designated as a highly inflationary economy. Historically, the U.S. dollar has been our functional currency for this market. As a result, there were no resulting gains or losses from a re-measurement of the financial statements using official rates of the Company’s Belarusian subsidiary.  However, as a result of the weakening of the Belarusian ruble, the purchasing power of our Distributors in this market has become diminished. During the three and nine months ended September 30, 2012, the Company’s Belarusian subsidiary’s net sales revenue represented approximately 1.6 percent and 1.5 percent of consolidated net sales revenue, respectively. The Company’s total and net assets related to Belarus as of September 30, 2012 and December 31, 2011 were insignificant.

Contract Termination Costs

In 1999 and 2000, the Company and NutriPlus LLC (“NutriPlus”) entered into an Asset Purchase Agreement and subsequent Settlement Agreement (together the “Purchase Agreement”) under which the Company acquired certain assets in order to establish its Russian business, and NutriPlus acquired rights to receive certain royalty payments from the Company expressed as a percentage of the Company’s net sales in its Russian business.

On July 8, 2011, the Company and NutriPlus entered into a settlement agreement, in which the Company agreed to pay NutriPlus $21,700 for the release of all past and future royalty obligations.  Of the $21,700, the Company applied $6,950 toward previously accrued and expensed but unpaid royalties, and $14,750 in exchange for the contract termination and extinguishment of future royalty obligations.

7

(2)Inventories

Inventories consist of the following:

	September 30,		December 31,
	2012		2011
Raw Materials	$	13,814	$	12,992
Work in Progress	931		1,230
Finished Goods	28,910		27,389
	$	43,655	$	41,611

(3)Intangible Assets

At September 30, 2012 and December 31, 2011, intangibles for product formulations had a gross carrying amount of $1,763 and $1,763, accumulated amortization of $723 and $612, and a net amount of $1,040 and $1,151, respectively. The estimated useful lives of the product formulations range from 9 to 15 years.

Amortization expense for intangible assets for the three months ended September 30, 2012 and 2011 was $37 and $37, respectively. Amortization expense for intangible assets for the nine months ended September 30, 2012 and 2011 was $111 and $111, respectively. Estimated amortization expense for each of the next five fiscal years is $149.

(4)Investments

The amortized cost and estimated fair values of available-for-sale securities by investment category are as follows:

As of September 30, 2012	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	709	$	36	$	—		$	745
U.S. government securities funds	990		—		(4		)	986
Equity securities	227		240		(6		)	461
Total short-term investment securities	$	1,926	$	276	$	(10	)	$	2,192

As of December 31, 2011	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	1,158	$	51	$	—		$	1,209
U.S. government securities funds	988		—		(5		)	983
Short-term deposits	3,104		—		—			3,104
Equity securities	227		159		(5		)	381
Total short-term investment securities	$	5,477	$	210	$	(10	)	$	5,677

The municipal obligations held at a fair value of $745 at September 30, 2012 all mature in less than three years.

During the nine month periods ended September 30, 2012 and 2011, the proceeds from the maturities and sales of available-for-sale securities were $3,689 and $5,650, respectively. There were no gross realized gains (losses) on sales of available-for-sale securities (net of tax) for the nine month periods ended September 30, 2012 and 2011, respectively.

The Company’s trading securities portfolio totaled $1,317 at September 30, 2012 and $1,429 at December 31, 2011, and generated gains of $44 and losses of $121 for the three months ended September 30, 2012 and 2011, respectively and generated gains of $104 and losses of $46 for the nine months ended September 30, 2012 and 2011, respectively.

As of September 30, 2012 and December 31, 2011, the Company had unrealized losses of $4 and $5, respectively, in its U.S. government securities funds. These losses are due to the interest rate sensitivity of the U.S. government securities funds.

(5)Long-Term Debt

On August 9, 2011, the Company entered into a Revolving Credit Agreement with Wells Fargo Bank, N. A., that permits the Company to borrow up to $15,000 through August 9, 2013, bearing interest at LIBOR plus 1.25 percent. The Company must pay an

8

annual commitment fee of 0.25 percent on the unused portion of the commitment. At September 30, 2012 and December 31, 2011, the Company had $15,000 available under this facility.

A term loan of $10,000 was obtained in conjunction with the Revolving Credit Agreement with Wells Fargo Bank, N. A., and has a maturity date of August 9, 2014, a variable interest rate of LIBOR plus 1.25 percent (1.50 percent as of September 30, 2012) and monthly amortization of principal. The term loan is collateralized by the Company’s manufacturing facility in Spanish Fork, Utah.

Long-term debt at September 30, 2012 and December 31, 2011 consists of the following:

	September 30,			December 31,
	2012			2011
Term loan due in monthly installments of approximately $285, including interest, secured by real estate	$	6,726		$	9,190
Less current installments	(3,334		)	(3,296		)
Long-term debt	$	3,392		$	5,894

The Revolving Credit Agreement contains restrictions on liquidity, leverage levels, minimum net income and consecutive quarterly net losses. In addition, the agreements restrict capital expenditures, lease expenditures, other indebtedness, liens on assets, guaranties, loans and advances, and the merger, consolidation and transfer of assets except in the ordinary course of business.  The Company is currently in compliance with these debt covenants.

(6)Net Income Per Share

Basic net income per common share (“Basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.

The following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September 30, 2012 and 2011:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2012		2011			2012		2011
Net income (loss)	$	6,370	$	(2,256	)	$	20,884	$	9,980
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Basic net income per common share:
Net income (loss) per common share	$	0.41	$	(0.14	)	$	1.34	$	0.64
Diluted weighted average shares outstanding
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Weighted average stock grants outstanding	343		—			314		130
Diluted weighted average shares outstanding	15,971		15,562			15,917		15,674
Diluted net income per common share:
Net income (loss) per common share	$	0.40	$	(0.14	)	$	1.31	$	0.64
Potentially dilutive shares excluded from diluted per share amounts:
Stock options	96		—			96		661
Potentially anti-dilutive shares excluded from diluted per share amounts:
Stock options	167		1,379			249		202

Potentially dilutive shares excluded from diluted per share amounts include performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved. Potentially anti-dilutive shares excluded from diluted per share amounts include both time-based stock options and unearned performance-based options to purchase shares of

9

common stock with exercise prices greater than the weighted average share price during the period and shares that would be anti-dilutive to the computation of dilutive net income per share for the three and nine months ended September 30, 2012 and 2011.

(7)Capital Transactions

Dividends

The declaration of future dividends is subject to the discretion of the Company’s Board of Directors and will depend upon various factors, including the Company’s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by its Board of Directors.

On May 7, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on May 29, 2012 to shareholders of record on May 18, 2012. On August 1, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on August 23, 2012 to shareholders of record on August 13, 2012.

Share-based Compensation

During the nine-month period ended September 30, 2012, the Company’s shareholders adopted and approved the Nature’s Sunshine Products, Inc. 2012 Stock Incentive Plan (the “2012 Incentive Plan”).  The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.  The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500 shares of the Company’s common stock were authorized for the granting of awards under the 2012 Incentive Plan. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.

The Company also maintains a stock incentive plan, which was approved by shareholders in 2009 (the “2009 Incentive Plan”). The 2009 Incentive Plan also provided for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.  Under the 2012 Incentive Plan, any shares subject to award, or awards forfeited or reacquired by the Company issued under the 2009 Incentive Plan are available for award up to a maximum of 400 shares.

The Company also maintained a stock option plan, which was approved by shareholders in 1995 and expired in 2005 (“the 1995 Stock Plan”). The 1995 Stock Plan provided for the granting or awarding of certain nonqualified stock options to officers, directors and other employees. The term, not to exceed 10 years, and the vesting and exercise period of each stock option awarded under the 1995 Stock Plan were determined by the Company’s Board of Directors.

Stock option activity for the nine months ended September 30, 2012 is as follows:

	Number of Shares		Weighted Average Exercise Price Per Share
Options outstanding at December 31, 2011	1,374		$	9.88
Granted	681		15.11
Expired	(6	)	8.59
Exercised	(191	)	10.34
Options outstanding at September 30, 2012	1,858		11.75

The Company’s outstanding stock options include time-based stock options which vest over differing periods ranging from the date of issuance up to 48 months from the option grant date, performance-based stock options which vest upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options, and performance-based stock options which vest upon achieving cumulative annual net sales revenue growth targets over a rolling two-year period subject to the Company maintaining at least an eight percent operating income margin during the applicable period.

10

During the nine-month period ended September 30, 2012, the Company issued time-based options to purchase 217 shares of common stock under the 2009 Incentive Plan to the Company’s new senior executives. These options were issued with a weighted average exercise price of $15.65 per share and a weighted average grant date fair value of $7.66 per share. All of the options issued have an option termination date of ten years from the option grant date.

Also, during the nine-month period ended September 30, 2012, the Company issued options to purchase 464 shares of common stock under the 2012 Incentive Plan to the Company’s executive officers and other employees, which are composed of both time-based stock options and net sales revenue performance-based stock options. These options were issued with a weighted average exercise price of $14.86 per share and a weighted average grant date fair value of $7.01 per share. All of the options issued have an option termination date of ten years from the option grant date.

The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted average assumptions for the nine month period ended September 30, 2012:

	2012
Expected life (in years)	4.0 to 6.0
Risk-free interest rate	0.3 to 0.9
Expected volatility	58.5 to 66.0
Dividend yield	0.0 to 1.3

Expected option lives and volatilities are based on historical data of the Company. The risk free interest rate is calculated as the average U.S. Treasury obligation rate that corresponds with the option life.

Share-based compensation expense from time-based stock options for the three-month periods ended September 30, 2012 and 2011 was approximately $630 and $166, respectively; the related tax benefit was approximately $246 and $66, respectively. Share-based compensation expense from time-based stock options for the nine-month periods ended September 30, 2012 and 2011 was approximately $1,299 and $390, respectively; the related tax benefit was approximately $513 and $156, respectively. As of September 30, 2012 and December 31, 2011, the unrecognized share-based compensation expense related to the grants described above was $3,285 and $607, respectively. As of September 30, 2012, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 1.9 years.

Share-based compensation expense from operating income performance-based stock options for the three-month periods ended September 30, 2012 and 2011was approximately $0 and $607, respectively; the related tax benefit was approximately $0 and $240, respectively. Shared-based compensation expense from operating income performance-based stock options for the nine-month periods ended September 30, 2012 and 2011was approximately $652 and $1,527, respectively; the related tax benefit was approximately $255 and $603, respectively. As of September 30, 2012 and December 31, 2011, the unrecognized share-based compensation expense related to these options was approximately $0 and $652, respectively. As of September 30, 2012, there is no remaining compensation expense to be recognized for the operating income performance-based stock options.

The Company has not recognized any share-based compensation expense related to the net sales revenue performance-based stock options for the three and nine-month periods ended September 30, 2012.  Should the Company attain all of the net sales revenue metrics related to the net sales revenue performance-based stock option grants, the Company could recognize up to $700 of potential share-based compensation expense.

At September 30, 2012, the aggregate intrinsic value of all outstanding stock options to purchase 1,858 shares of common stock, exercisable stock options to purchase 1,061 shares of common stock and stock options to purchase 660 shares of common stock that are expected to vest (net of expected forfeitures) was $8,367, $7,213 and $1,085, respectively. At December 31, 2011, the aggregate intrinsic value of outstanding options to purchase 1,374 shares of common stock, the exercisable options to purchase 772 shares of common stock, and options to purchase 602 shares of common stock expected to vest (net of expected forfeitures) was $7,757, $4,819 and $2,732, respectively.

Restricted stock unit activity for the nine months ended September 30, 2012 is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Units outstanding at December 31, 2011	—	$	—
Granted	18	12.07
Vested	—	—
Forfeited	—	—
Units outstanding at September 30, 2012	18	12.07

11

During the nine-month period ended September 30, 2012, the Company issued 18 restricted stock units (RSUs) of common stock under the 2012 Incentive Plan to the Board of Directors. The RSUs were issued with a weighted average grant date fair value of $12.07 per share and vest over a one year period from the grant date.

RSUs are valued at the market value on the date of grant.  Due to post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. The Finnerty Model proposes to estimate a discount for lack of marketability such as transfer restrictions by using an option pricing theory. This model has gained recognition through its ability to address the magnitude of the discount by considering the volatility of a company’s stock price and the length of restriction. The concept underpinning the Finnerty Model is that restricted stock cannot be sold over a certain period of time.

Share-based compensation expense from RSUs for the three and nine-month periods ended September 30, 2012 was approximately $50 and the related tax benefit was approximately $20. As of September 30, 2012, the unrecognized share-based compensation expense related to the grants described above was $173. As of September 30, 2012, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.7 years.

(8)Segment Information

The Company has three business segments. These business segments are components of the Company for which separate information is available that is evaluated regularly by the chief executive officer in deciding how to allocate resources and in assessing relative performance.

The Company has two business segments that operate under the Nature’s Sunshine Products brand and are divided based on their geographic operations in the United States (NSP United States) and in countries outside the United States (NSP International). The Company’s third business segment operates under the Synergy WorldWide brand, which distributes its products through different marketing and distributor compensation plans and products with formulations that are sufficiently different from those of NSP United States and NSP International to warrant accounting for these operations as a separate business segment. Net sales revenues and operating income (loss) for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer.

Reportable business segment information is as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Net sales revenue:
Nature’s Sunshine Products:
United States	$	33,695		$	33,519		$	104,053		$	105,061
International	31,275			33,059			97,187			102,661
	64,970			66,578			201,240			207,722
Synergy WorldWide	26,262			24,524			75,851			68,035
Total net sales revenue	91,232			91,102			277,091			275,757
Operating expenses:
Nature’s Sunshine Products:
United States	31,001			31,176			94,230			95,257
International	27,826			43,151			85,860			108,852
	58,827			74,327			180,090			204,109
Synergy WorldWide	23,700			21,880			68,811			61,080
Total operating expenses	82,527			96,207			248,901			265,189
Operating income (loss):
Nature’s Sunshine Products:
United States	2,694			2,343			9,823			9,804
International	3,449			(10,092		)	11,327			(6,191		)
	6,143			(7,749		)	21,150			3,613
Synergy WorldWide	2,562			2,644			7,040			6,955
Total operating income (loss)	8,705			(5,105		)	28,190			10,568
Other income (expense), net	(214		)	1,204			(159		)	1,049
Income (loss) before provision for income taxes	$	8,491		$	(3,901	)	$	28,031		$	11,617

12

NSP International’s operating loss of $10,092 and $6,191 for the three and nine months ended September 30, 2011, includes $14,750 of contract termination costs related to the Company’s arbitration settlement with NutriPlus LLC (described further in Note 1, Basis of Presentation).

From an individual country perspective, only the United States comprises 10 percent or more of consolidated net sales revenue for the three and nine-month periods ended September 30, 2012 and 2011 as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Net sales revenue:
United States	$	38,243	$	38,885	$	118,390	$	120,868
Other	52,989		52,217		158,701		154,889
	$	91,232	$	91,102	$	277,091	$	275,757

Revenue generated by each of the Company’s product lines is set forth below:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
NSP United States:
Herbal products	$	17,809	$	17,441	$	56,010	$	55,344
Vitamin, mineral and other nutritional supplements	14,296		14,280		43,061		43,204
Personal care products	970		1,011		2,976		3,328
Other products	620		787		2,006		3,185
	33,695		33,519		104,053		105,061
NSP International:
Herbal products	$	16,913	$	18,502	$	52,188	$	56,244
Vitamin, mineral and other nutritional supplements	12,037		12,053		37,191		37,631
Personal care products	1,944		2,128		6,660		7,473
Other products	381		376		1,148		1,313
	31,275		33,059		97,187		102,661
Synergy WorldWide:
Herbal products	$	10,005	$	9,797	$	29,982	$	27,428
Vitamin, mineral and other nutritional supplements	14,510		12,699		40,575		34,668
Personal care products	1,394		1,378		4,020		4,230
Other products	353		650		1,274		1,709
	26,262		24,524		75,851		68,035
	$	91,232	$	91,102	$	277,091	$	275,757

From an individual country perspective, only the United States and Venezuela comprise 10 percent or more of consolidated property, plant and equipment as follows:

	September 30, 2012		December 31, 2011
Property, plant and equipment:
United States	$	20,951	$	18,119
Venezuela	3,636		3,939
Other	3,388		3,079
Total property, plant and equipment	$	27,975	$	25,137

13

(9)       Income Taxes

Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the periods in which they occur. For the three months ended September 30, 2012 and 2011, the Company’s provision (benefit) for income taxes, as a percentage of income (loss) before income taxes was 25.0 percent and (42.2) percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.  For the nine months ended September 30, 2012 and 2011, the Company’s provision for income taxes, as a percentage of income before income taxes was 25.5 percent and 14.1 percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.

The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.8 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.2 percent).

The difference between the effective tax rate and the U.S. federal statutory rate for the three months ended September 30, 2011 was primarily attributed to the pretax loss related to contract termination costs, in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-3.9 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.0 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2011 was primarily attributed to contract termination costs (-9.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-11.5 percent).

The Company’s U.S. federal income tax returns for 2003 through 2005, and 2009 through 2011 are open to examination for federal tax purposes. The Company has several foreign tax jurisdictions that have open tax years from 2004 through 2011. The Internal Revenue Service (“IRS”) is currently conducting an audit of the Company’s U.S. federal income tax returns for the 2009 and 2010 tax years.

In October 2009, the IRS issued an examination report formally proposing adjustments with respect to the 2003 through 2005 taxable years, which primarily related to the prices that were charged in intra-group transfers of property and the disallowance of related deductions. The Company challenged the IRS proposals, and took the matter before the Office of Appeals of the Internal Revenue Service.  A settlement was reached with IRS Appeals and a proposed settlement agreement was signed by NSP in January 2012. As of September 30, 2012, the Company has made all required payments related to this matter and, absent further comment from the IRS, the examination period for the 2003 through 2005 taxable years will close on December 31, 2012.

During 2011, the IRS issued an examination report formally proposing adjustments with respect to the 2006 through 2008 taxable years.  As with the previous examination cycle discussed above, the adjustments related primarily to the prices that were charged in intra-group transfers of property and the disallowance of related deductions.  The Company reached a settlement of the issues with the IRS examination team and an agreement was signed by the Company in January 2012.  On March 7, 2012, the Company received a letter from the IRS examination team stating that they accepted the examination report and do not plan to make additional changes. The Company has made all required payments related to this matter and the examination period for the 2006 through 2008 taxable years are now closed.

As of September 30, 2012, the Company had accrued $9,772 related to unrecognized tax positions compared with $10,426 as of December 31, 2011. This net decrease was primarily attributed to the expiration of the statute of limitations on certain liabilities in various foreign jurisdictions.

Changes to the effective rate due to dividends received from foreign subsidiaries, impact of foreign tax credits and the unremitted earnings calculation are expected to be recurring; however, depending on various factors, the changes may be favorable or unfavorable in a particular period. The Company’s aggregate consolidated effective tax rate will typically reflect differences between the lower statutory rates in foreign markets compared to the U.S. statutory rate of 35 percent. Given the large number of jurisdictions in which the Company does business and the number of factors that can impact effective tax rates in any given year, the consolidated effective rate is likely to reflect relatively significant fluctuations from year-to-year.

Although the Company believes its estimates related to its unrecognized tax benefits are reasonable, the Company can provide no assurances that the final tax outcome of these matters will not be different from that which it has reflected in its historical income

14

tax provisions and accruals. Any difference in the final tax outcome of these matters could have a material impact on the Company’s income tax provision and operating results in the periods in which the Company makes such determination.

(10)Commitments and Contingencies

Legal Proceedings

The Company is party to various legal proceedings related to value-added tax assessments and other civil litigation. Management cannot predict the ultimate outcome of these proceedings, individually or in the aggregate, or their resulting effect on the Company’s business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Therefore, no provision for losses has been provided. The Company believes future payments related to these matters could range from $0 to approximately $1,000. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the business, financial position, results of operations or cash flows for the periods in which the ruling occurs and/or future periods. The Company maintains directors’ and officers’ liability, product liability, general liability and excess liability insurance coverage. However, no assurances can be given that such insurance will continue to be available at an acceptable cost to the Company, that such coverage will be sufficient to cover one or more large claims, or that the insurers will not successfully disclaim coverage as to a pending or future claim.

Non-income Tax Contingencies

The Company has reserved for certain foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management’s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. The Company provides provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes. As of September 30, 2012 and December 31, 2011, accrued liabilities include $6,580 and $6,921, respectively, related to non-income tax contingencies. While management believes that the assumptions and estimates used to determine this liability are reasonable, the ultimate outcome of those matters cannot presently be determined. The Company is not able at this time to predict the ultimate outcomes of those matters or to estimate the effect of the ultimate outcomes, if greater than the amounts accrued, would have on the financial condition, results of operations or cash flows of the Company.

Government Regulations

The Company is subject to governmental regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and to the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determinations that either the Company or the Company’s Distributors are not in compliance with existing statutes, laws, rules or regulations could potentially have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations, or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance, in all material respects, with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

(11)Fair Value Measurements

The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

15

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of September 30, 2012:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	745	$	—	$	745
U.S. government security funds	986		—		—		986
Equity securities	461		—		—		461
Investment securities	1,317		—		—		1,317
Total assets measured at fair value on a recurring basis	$	2,764	$	745	$	—	$	3,509

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of December 31, 2011:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	1,209	$	—	$	1,209
U.S. government security funds	983		—		—		983
Short-term deposits	—		3,104		—		3,104
Equity securities	381		—		—		381
Investment securities	1,429		—		—		1,429
Total assets measured at fair value on a recurring basis	$	2,793	$	4,313	$	—	$	7,106

Investments available for sale — The majority of the Company’s investment portfolio consists of various securities, such as state and municipal obligations, U.S. government security funds, short-term deposits and various equity securities.  The Level 1 securities are valued using quoted prices for identical assets in active markets including equity securities and U.S. government treasuries.  The Level 2 securities include investments in state and municipal bonds whereby all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset.

Investment securities — The majority of the Company’s trading portfolio consists of various marketable securities that are using quoted prices in active markets.

For the nine months ended September 30, 2012 and for the year ended December 31, 2011, there were no fair value measurements using the significant unobservable inputs (Level 3).

The carrying amounts reflected on the consolidated balance sheet for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying amount reflected in the consolidated balance sheet for long-term debt approximates fair value due to the interest rate on the debt being variable based on current market rates. During the three months ended September 30, 2012 and 2011, the Company did not have any write-offs related to the re-measurement of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.

16

Item 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following Management’s Discussion and Analysis should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this report, as well as the consolidated financial statements, the notes thereto, and management’s discussion and analysis included in our Annual Report on Form 10-K for the year ended December 31, 2011, and our Reports on Form 8-K, that have been filed with the SEC since then through the date of this report.

Throughout this report, we refer to Nature’s Sunshine Products, Inc., together with its subsidiaries, as “we,” “us,” “our,” “Company” or “the Company.”

OVERVIEW

Nature’s Sunshine Products, Inc., together with its subsidiaries, is a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. The Company is a Utah corporation with its principal place of business in Lehi, Utah, and sells its products to a sales force of independent Managers, Distributors and customers who use the products themselves or resell them to other Distributors or customers. The formulation, manufacturing, packaging, labeling, advertising, distribution and sale of each of our major product groups are subject to regulation by one or more governmental agencies.

The Company has two reportable business segments that operate under the Nature’s Sunshine Products brand and are divided based on their geographic operations in the United States (NSP United States) and in countries outside the United States (NSP International). We also sell our products through a separate division and operating business segment, Synergy WorldWide. Synergy WorldWide offers marketing plans, Distributor compensation plans and product formulations that are sufficiently different from those of NSP United States and NSP International to warrant its treatment as a separately reportable business segment.

We market our products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, Indonesia, Ireland, Japan, Kazakhstan, Latvia, Lithuania, Malaysia, Mexico, Moldova, Mongolia, the Netherlands, Nicaragua, Norway, Panama, Peru, the Philippines, Poland, Russia, Singapore, South Korea, Spain, Sweden, Taiwan, Thailand, the Ukraine, the United Kingdom, the United States, Venezuela and Vietnam. We export our products to several other countries, including Argentina, Australia, Chile, Israel and New Zealand.

During the third quarter of 2012, our consolidated net sales revenue increased approximately 0.1 percent compared to the third quarter of 2011, however, net sales revenue increased by 2.1 percent in local currencies excluding the negative impact of foreign currency fluctuations. Synergy WorldWide’s net sales revenue increased approximately 7.1 percent, however, net sales revenue increased by 13.1 percent in local currencies excluding the negative impact of foreign currency fluctuations. NSP International’s net sales revenue decreased approximately 5.4 percent compared to the same period in 2011 (or 4.4 percent excluding the negative impact of foreign currency fluctuations), while NSP United States net sales revenue increased approximately 0.5 percent compared to the same period in 2011. The significant sales revenue growth of Synergy WorldWide was from Europe and Korea during 2012. Gains in these markets were partially offset by decreases in our NSP Mexico, Peru, and Japan markets and our Synergy Japan market.

Over the same period, selling, general and administrative costs as a percentage of net sales revenue for the quarter decreased from 35.0 percent in the prior year period to 34.7 percent in the current year as a result of revenue growth (primarily in Synergy WorldWide), reductions in variable costs for NSP Mexico and Synergy Japan, as well as favorable currency rate fluctuation, partially offset by increases in variable costs for Synergy Europe and Korea, and NSP Russia, net changes in sales tax reserves and U.S. healthcare costs.

We distribute our products to consumers through an independent sales force comprised of Managers and Distributors. A person who joins our independent sales force begins as a “Distributor.” A Distributor interested in earning additional income by committing more time and effort to selling our products may earn “Manager” status. Manager status is contingent upon attaining certain purchase volume levels, recruiting additional Distributors, and demonstrating leadership abilities. Active Managers worldwide totaled approximately 28,700 and 28,200 at September 30, 2012 and 2011, respectively. Active Distributors and customers worldwide totaled approximately 656,800 and 682,300 at September 30, 2012 and 2011, respectively.

17

RESULTS OF OPERATIONS

The following table summarizes our unaudited consolidated operating results in U.S. dollars and as a percentage of net sales revenue for the three months ended September 30, 2012 and 2011 (dollar amounts in thousands).

	2012					2011					Change from
	Total			Percent of		Total			Percent of		2012 to 2011
	dollars			net sales		dollars			net sales		Dollar			Percentage
Net sales revenue	$	91,232		100.0	%	$	91,102		100.0	%	$	130		0.1	%
Costs and expenses:
Cost of goods sold	17,713			19.4		16,879			18.5		834			4.9
Volume incentives	33,155			36.3		32,733			35.9		422			1.3
SG&A expenses	31,659			34.7		31,845			35.0		(186		)	(0.6	)
Contract termination costs	—			0.0		14,750			16.2		(14,750		)	(100.0	)
Total operating expenses	82,527			90.4		96,207			105.6		(13,680		)	(14.2	)
Operating income (loss)	8,705			9.6		(5,105		)	(5.6	)	13,810			270.5
Other income (expense), net	(214		)	(0.3	)	1,204			1.3		(1,418		)	(117.8	)
Income (loss) before provision for income taxes	8,491			9.3		(3,901		)	(4.3	)	12,392			317.7
Provision (benefit) for income taxes	2,121			2.3		(1,645		)	(1.8	)	3,766			228.9
Net income (loss)	$	6,370		7.0	%	$	(2,256	)	(2.5	)%	$	8,626		382.4	%

The following table summarizes our unaudited consolidated operating results in U.S. dollars and as a percentage of net sales revenue for the nine months ended September 30, 2012 and 2011 (dollar amounts in thousands).

	2012					2011				Change from
	Total			Percent of		Total		Percent of		2012 to 2011
	dollars			net sales		dollars		net sales		Dollar			Percentage
Net sales revenue	$	277,091		100.0	%	$	275,757	100.0	%	$	1,334		0.5	%
Costs and expenses:
Cost of goods sold	53,159			19.2		52,560		19.1		599			1.1
Volume incentives	100,276			36.2		100,421		36.4		(145		)	(0.1	)
SG&A expenses	95,466			34.4		97,458		35.3		(1,992		)	(2.0	)
Contract termination costs	—			0.0		14,750		5.4		(14,750		)	(100.0	)
Total operating expenses	248,901			89.8		265,189		96.2		(16,288		)	(6.1	)
Operating income	28,190			10.2		10,568		3.8		17,622			166.7
Other income (expense), net	(159		)	(0.1	)	1,049		0.4		(1,208		)	(115.2	)
Income before provision for income taxes	28,031			10.1		11,617		4.2		16,414			141.3
Provision for income taxes	7,147			2.6		1,637		0.6		5,510			336.6
Net income	$	20,884		7.5	%	$	9,980	3.6	%	$	10,904		109.3	%

Net Sales Revenue

Consolidated net sales revenue for the three and nine months ended September 30, 2012 was $91.2 million and $277.1 million compared to $91.1 million and $275.8 million for the same periods in 2011, increases of approximately 0.1 percent and 0.5 percent, respectively, however, in local currencies, net sales increased 2.1 percent and 2.0 percent for the three and nine months ended September 30, 2012, respectively. Fluctuation in foreign exchange rates had a $1.8 million and $4.3 million unfavorable impact on net sales for the three and nine months ended September 30, 2012, respectively. The increases in net sales revenue for the three and nine months ended September 30, 2012 compared to the same periods in 2011 are primarily due to growth in Synergy WorldWide, offset by declines in NSP International.

18

NSP United States

Net sales revenue for our NSP United States segment for the three and nine months ended September 30, 2012 was $33.7 million and $104.1 million compared to $33.5 million and $105.1 million for the same periods in 2011, or an increase of 0.5 percent and a decrease of 1.0 percent, respectively, in 2012 compared to 2011. Net sales for NSP United States core products (herbal products vitamin, mineral, and other nutritional supplements, and personal care products) increased by 1.0 percent, but were offset by the discontinuance of non-core products (other products including essential oils, sales aids and other miscellaneous products) for the quarter. Active Managers within NSP United States totaled approximately 5,300 and 5,600 at September 30, 2012 and 2011, respectively. Active Distributors and customers within NSP United States totaled approximately 191,500 and 210,300 at September 30, 2012 and 2011, respectively. Managers and Distributors within NSP United States are predominantly practitioners of nutritional supplement therapies and retailers and consumers of our products. The number of active Managers, Distributors and customers decreased due to lower retention, partially offset by a modest improvement in recruiting.

NSP United States includes both English and Spanish language sales divisions, of which the English language division is approximately 80 percent of segment net sales revenue. The English language division net sales revenue decreased $0.2 million and $1.0 million, or a decrease of 0.9 percent and 1.2 percent, respectively, for the three and nine months ended September 30, 2012, compared to the same period in 2011. The Spanish language division net sales revenue increased $0.4 million and was flat, or 5.8 percent and 0.0 percent, respectively, for the three and nine months ended September 30, 2012, compared to the same period in 2011.

NSP International

NSP International reported net sales revenue for the three and nine months ended September 30, 2012 of $31.3 million and $97.2 million, compared to $33.1 million and $102.7 million for the same periods in 2011, decreases of approximately 5.4 percent and 5.3 percent, respectively, however, in local currencies, net sales decreased 4.4 percent and 4.2 percent, respectively. Fluctuation in foreign exchange rates had a $0.3 million and $1.1 million unfavorable impact on net sales for the three and nine months ended September 30, 2012, respectively. Active Managers within NSP International totaled approximately 20,200 and 20,000 at September 30, 2012 and 2011, respectively. Active Distributors and customers within NSP International totaled approximately 376,200 and 387,000 at September 30, 2012 and 2011, respectively. Managers and Distributors within NSP International are predominantly practitioners of nutritional supplement therapies and retailers or consumers of our products, with the exception of our Russian markets which are more network marketing oriented. The number of active Distributors and customers decreased in NSP International due to lower retention in a small number of markets, partially offset by a modest improvement in recruiting.

Notable activity in the following markets contributed to the results of NSP International:

In our Russian markets (Russia, the Ukraine, Belarus and several other Eastern European nations), net sales revenues decreased approximately $0.1 million and $0.4 million, or a decrease of 0.9 percent and 1.0 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. The decrease in year-to-date net sales revenue was related to the depreciation of the Russian ruble, which has adversely affected our Russian Distributors’ ability to purchase our products, and may continue to adversely affect sales going forward. Net sales revenue in Russia decreased by $0.5 million and $0.9 million for the three and nine months ended September 30, 2012, respectively, compared to the same period in 2011. The decrease in Russian sales was partially offset by sales increases in Belarus and the Ukraine for the three and nine months ended September 30, 2012, respectively.

In Mexico, our net sales revenues decreased approximately $0.3 million and $1.4 million, or 11.4 percent and 14.8 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. In local currency, net sales decreased 5.2 percent and 6.2 percent, respectively, compared to the same periods in 2011. Fluctuations in foreign exchange rates had a $0.3 million and $0.8 million unfavorable impact on net sales for the three and nine months ended September 30, 2012. The decrease in sales is due to lower Manager and Distributor activity, which has been compounded by a local management team that is currently being restructured and augmented.

In Peru, our net sales revenues decreased approximately $0.7 million and $2.0 million, or 74.9 percent and 65.0 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. Fluctuations in foreign exchange rates had a nominally favorable impact on net sales for the periods. The decrease in net sales is principally due to a change in local regulations that has restricted our ability to sell several of our key products in this market through a direct selling business model. We continue to evaluate our product mix and selling model for Peru.

In Japan, our net sales revenues decreased approximately $0.1 million and $0.8 million, or 7.2 percent and 14.7 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011.  Fluctuations in foreign exchange rates had a nominally favorable impact on net sales for the periods compared to the same periods in 2011. The decrease in local currency sales is primarily due to the continued lower activity in our existing Manager and Distributor base following the 2011 natural disasters.

19

Synergy WorldWide

Synergy WorldWide reported net sales revenue for the three and nine months ended September 30, 2012 of $26.3 million and $75.9 million, compared to $24.5 million and $68.0 million in 2011, increases of approximately 7.1 percent and 11.5 percent, respectively. In local currencies, net sales increased 13.1 percent and 16.2 percent for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. Fluctuations in foreign exchange rates had a $1.5 million and $3.2 million unfavorable impact on net sales for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. Active Managers within Synergy WorldWide totaled approximately 3,200 and 2,600 at September 30, 2012 and 2011, respectively. Active Distributors and customers within Synergy WorldWide totaled approximately 89,100 and 85,000 at September 30, 2012 and 2011, respectively.

Notable activity in the following markets contributed to the results of Synergy WorldWide:

In Europe, our net sales revenues increased approximately $0.6 million and $4.6 million, or 9.4 percent and 28.8 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011, however, in local currency, our net sales increased 23.6 percent and 41.2 percent, respectively, compared to the same periods in 2011.  Fluctuations in foreign exchange rates had a $0.9 million and $2.0 million unfavorable impact on net sales for the three and nine months ended September 30, 2012 compared to the same periods in 2011. Strong Distributor leadership in recruiting and training efforts continues to effectively build our Distributor base thereby driving increased market penetration.

In Korea, our net sales revenues increased approximately $2.1 million and $7.2 million, or 38.0 percent and 51.9 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011, however, in local currency, our net sales increased 44.6 percent and 58.2 percent, compared to the same periods in 2011.  Fluctuations in foreign exchange rates had a $0.4 million and $0.9 million unfavorable impact on net sales for the three and nine months ended September 30, 2012, compared to the same periods in 2011. Net sales growth is due to continued collaboration between the Company and key Distributor leadership in developing sales groups with a strong selling system and a broad product line that is well accepted in Korea.

In Japan, our net sales revenues decreased approximately $1.0 million and $3.3 million, or 27.1 percent and 29.9 percent, for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011. Fluctuations in foreign exchange rates had a nominally favorable impact on net sales for the periods. The decrease in local currency sales is partially due to the challenging Japanese direct selling market and the continued difficulty in rebounding since the 2011 natural disasters. In addition, unusually high product returns during the first quarter related to a specific promotion contributed significantly to reduced net sales revenue for the nine months. Product returns for the second and third quarters were insignificant and the product returns in the first quarter were not related to product quality.

Further information related to NSP United States, NSP International and Synergy WorldWide business segments is set forth in Note 8 to the Unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 of this report.

Cost of Goods Sold

Cost of goods sold as a percent of net sales revenue increased to 19.4 percent and 19.2 percent for the three and nine months ended September 30, 2012, compared to 18.5 percent and 19.1 percent for the same periods in 2011. Changes in the cost of goods sold are primarily the result of changes in product mix between markets. The cost of goods sold rates were greater in 2012 than in 2011 due to promotions related to new product launches and national/regional conventions in addition to rising production costs of certain raw materials.  While the Company intends to seek continued cost reductions where possible, pricing pressure on raw materials, fuel costs and other factors could adversely affect our ability to reduce or maintain our current cost of goods sold rate in the future.

Volume Incentives

Volume incentives are a significant part of our direct sales marketing program, and represent commission payments made to our independent Managers and Distributors. These payments are designed to provide incentives for reaching higher sales levels and for recruiting additional Distributors.  Volume incentives vary slightly, on a percentage basis, by product due to our pricing policies and commission plans in place in our various operations.  Volume incentives as a percent of net sales revenue increased to 36.3 percent and decreased to 36.2 percent for the three and nine months in 2012, compared to 35.9 percent and 36.4 percent for the same periods in 2011.

20

Selling, General and Administrative

Selling, general and administrative expenses decreased to 34.7 percent and 34.4 percent of net sales revenue for the three and nine months ended September 30, 2012, compared to 35.0 percent and 35.3 percent in 2011, or by approximately $0.2 million and $2.0 million to $31.7 million and $95.5 million for the three and nine months ended September 30, 2012, respectively.

Significant increases to selling, general and administrative expenses during the three and nine months ended September 30, 2012, compared to the same period in 2011 included:

·$1.2 million and $3.5 million of increased variable costs related to the sales growth of Synergy WorldWide in Europe, and Korea; and

·$1.1 million and $2.3 million of increased compensation related costs for U.S. employees.

Significant decreases to selling, general and administrative expenses during the three and nine months ended September 30, 2012, compared to the same period in 2011 included:

·$0.7 million and $2.5 million decrease in variable costs related to lower sales of NSP Japan and the United States and Synergy Japan;

·$0.6 million and $0.6 million of decreased professional fees related to the United States;

·$0.5 million and $1.1 million of favorable currency fluctuations;

·$0.4 million and $0.2 million for U.S. incentive related trips;

·$0.2 million and $1.4 million of decreased professional fees related to our Russian business as a result of the NutriPlus LLC settlement; and

·$0.0 million and $2.9 million of decreased royalty costs related to our Russian business as a result of the NutriPlus LLC settlement.

Contract Termination Costs

In 1999 and 2000, the Company and NutriPlus LLC (“NutriPlus”) entered into an Asset Purchase Agreement and subsequent Settlement Agreement (together the “Purchase Agreement”) under which the Company acquired certain assets in order to establish its Russian business, and NutriPlus acquired rights to receive certain royalty payments from the Company expressed as a percentage of the Company’s net sales in its Russian business.

On July 8, 2011, the Company and NutriPlus entered into a settlement agreement, in which the Company agreed to pay NutriPlus $21.7 million for the release of all past and future royalty obligations.  Of the $21.7 million, the Company applied $7.0 million toward previously accrued and expensed but unpaid royalties, and $14.7 million in exchange for the contract termination and extinguishment of future royalty obligations.

As a result of the settlement, our selling general and administrative expenses benefitted from the elimination of these related royalty expenses (as noted above).  If the Company had not entered into the settlement, our estimated royalty costs would have been $1.3 million and $4.2 million for the three and nine months ended September 30, 2012, and would have increased by $1.3 million for both the three and nine month periods ended September 30, 2011.  As a result of the settlement, the Company has been able to use a portion of the savings from the reduction of royalties to invest in programs and activities designed to develop future revenue growth.

See Note 1, Basis of Presentation in the Condensed Notes to the Consolidated Financial Statements for further discussion.

Operating Income (Loss)

Consolidated operating income increased approximately $13.8 million during the three months ended September 30, 2012, compared to the same period in 2011, from an operating loss of $5.1 million to $8.7 million. For the nine months ended September 30, 2012, operating income increased approximately $17.6 million, compared to the same period in 2011, from $10.6 million to $28.2 million. Excluding the NutriPlus related contract termination costs of $14.7 million, consolidated pro forma operating income decreased approximately $0.9 million during the three months ended September 30, 2012, compared to the same period in 2011, from $9.6 million to $8.7 million. For the nine months ended September 30, 2011, pro forma operating income increased approximately $2.9 million, compared to the same period in 2010, from $25.3 million to $28.2 million. Pro forma operating income decreased to 9.6 percent and increased to 10.2 percent of net sales for the three and nine months ended September 30, 2011, compared to 10.6 percent and 9.2 percent for the same periods in 2011, respectively.

Operating income for NSP United States increased $0.4 million and was flat for the three and nine months ended September 30, 2012, compared to the same period in 2011, from $2.3 million and $9.8 million to $2.7 million and $9.8 million, respectively. The increase in operating income for the three months ended September 30, 2012 compared to the same period 2011 is primarily the result of the increase in net sales revenue as well as a decrease of professional fees expense offset by increases in cost of goods sold and other selling, general and administrative expenses related to employee compensation costs.

Operating income for NSP International increased approximately $13.5 million and $17.5 million for the three and nine months ended September 30, 2012, compared to the same periods in 2011, from an operating loss of $10.1 million and operating income of

21

$6.2 million to operating income of $3.4 million and $11.3 million, respectively.  Excluding the NutriPlus related contract termination costs of $14.7 million, pro forma operating income for NSP International decreased approximately $1.2 million and increased $2.8 million for the three and nine months ended September 30, 2012, compared to the same periods in 2011, from $4.6 million and $8.5 million to $3.4 million and $11.3 million, respectively. The quarter-to-date decrease in pro forma operating income was primarily the result of lower net sales in our Japan, Mexico and Peru markets.  The increase in year-to-date operating income was primarily the result of the elimination of royalty fees and lower professional fees in our Russian markets related to the termination of the Company’s contract with NutriPlus, offset by lower net sales in our Japan, Mexico and Peru markets.

Operating income for Synergy WorldWide decreased $0.1 million and increased $0.1 million for the three and nine months ended September 30, 2012, respectively, compared to the same periods in 2011, from $2.6 million and $7.0 million to $2.6 million and $7.0 million, respectively.

Other Income (Expense), Net

Other income (expense), net for the three and nine months ended September 30, 2012 decreased $1.4 million and $1.2 million, respectively, compared to the same periods in 2011. The decrease in other income (expense), net in 2012 is due to increased foreign exchange losses in 2012 compared to 2011 and by the receipt of $0.7 million in restricted cash in Venezuela that had been previously written-down that was recovered in 2011.

Income Taxes

Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the periods in which they occur. For the three months ended September 30, 2012 and 2011, the Company’s provision (benefit) for income taxes, as a percentage of income (loss) before income taxes was 25.0 percent and (42.2) percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.  For the nine months ended September 30, 2012 and 2011, the Company’s provision for income taxes, as a percentage of income before income taxes was 25.5 percent and 14.1 percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.

The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.8 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.2 percent).

The difference between the effective tax rate and the U.S. federal statutory rate for the three months ended September 30, 2011 was primarily attributed to the pretax loss related to contract termination costs, in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-3.9 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.0 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2011 was primarily attributed to contract termination costs (-9.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-11.5 percent).

The Company’s U.S. federal income tax returns for 2003 through 2005, and 2009 through 2011 are open to examination for federal tax purposes. The Company has several foreign tax jurisdictions that have open tax years from 2004 through 2011. The Internal Revenue Service (“IRS”) is currently conducting an audit of the Company’s U.S. federal income tax returns for the 2009 and 2010 tax years.

In October 2009, the IRS issued an examination report formally proposing adjustments with respect to the 2003 through 2005 taxable years, which primarily related to the prices that were charged in intra-group transfers of property and the disallowance of related deductions. The Company challenged the IRS proposals, and took the matter before the Office of Appeals of the Internal Revenue Service.  A settlement was reached with IRS Appeals and a proposed settlement agreement was signed by NSP in January 2012. The Company has made all required payments as of September 30, 2012 related to this matter and, absent further comment from the IRS, the examination period for the 2003 through 2005 taxable years will close on December 31, 2012.

22

During 2011, the IRS issued an examination report formally proposing adjustments with respect to the 2006 through 2008 taxable years.  As with the previous examination cycle discussed above, the adjustments related primarily to the prices that were charged in intra-group transfers of property and the disallowance of related deductions.  The Company reached a settlement of the issues with the IRS examination team and an agreement was signed by the Company in January 2012.  On March 7, 2012, the Company received a letter from the IRS examination team stating that they accepted the examination report and do not plan to make additional changes. The Company has made all required payments related to this matter and the examination period for the 2006 through 2008 taxable years has now closed.

As of September 30, 2012, the Company had accrued $9,772 related to unrecognized tax positions compared with $10,426 as of December 31, 2011. This net decrease was primarily attributed to the expiration of the statute of limitations on certain liabilities in various foreign jurisdictions.

Changes to the effective rate due to dividends received from foreign subsidiaries, impact of foreign tax credits and the unremitted earnings calculation are expected to be recurring; however, depending on various factors, the changes may be favorable or unfavorable in a particular period. The Company’s aggregate consolidated effective tax rate will typically reflect differences between the lower statutory rates in foreign markets compared to the U.S. statutory rate of 35 percent. Given the large number of jurisdictions in which the Company does business and the number of factors that can impact effective tax rates in any given year, the consolidated effective rate is likely to reflect relatively significant fluctuations from year-to-year.

Although the Company believes its estimates related to its unrecognized tax benefits are reasonable, the Company can provide no assurances that the final tax outcome of these matters will not be different from that which it has reflected in its historical income tax provisions and accruals. Any difference in the final tax outcome of these matters could have a material impact on the Company’s income tax provision and operating results in the periods in which the Company makes such determination.

Product Categories

Our line of products includes herbal products, vitamin, mineral and other nutritional supplements, personal care products and other complementary products such as sales aids. We purchase herbs and other raw materials in bulk and, after quality control testing, we formulate, encapsulate, tablet or concentrate them, and package them for shipment. Most of our products are manufactured at the Company’s owned and operated facility in Spanish Fork, Utah. Contract manufacturers produce some of our vitamin, mineral and other nutritional supplements, personal care products and certain other miscellaneous products in accordance with our specifications and standards. We have implemented stringent quality control procedures to verify that our contract manufacturers have complied with our specifications and standards.

Presented below are the U.S. dollar amounts and associated revenue percentages from the sale of herbal products, vitamin, mineral and other nutritional supplements, personal care products, and other complementary products for the three and nine months ended September 30, 2012 and 2011, by business segment. The Company has two business segments that operate under the Nature’s Sunshine Products brand and are divided based on their geographic operations in the United States (NSP United States) and in countries outside the United States (NSP International). The Company’s third business segment operates under the Synergy WorldWide brand, which distributes its products through different marketing and distributor compensation plans and products with formulations that are sufficiently different from those of the NSP United States and NSP International to warrant accounting for these operations as a separate business segment.

Revenue generated by each of the Company’s product lines is set forth below:

23

	Three Months Ended September 30,
	2012				2011
NSP United States:
Herbal products	$	17,809	52.9	%	$	17,441	52.0	%
Vitamin, mineral and other nutritional supplements	14,296		42.4		14,280		42.6
Personal care products	970		2.9		1,011		3.0
Other products	620		1.8		787		2.4
	33,695		100.0	%	33,519		100.0	%
NSP International:
Herbal products	$	16,913	54.1	%	$	18,502	56.0	%
Vitamin, mineral and other nutritional supplements	12,037		38.5		12,053		36.5
Personal care products	1,944		6.2		2,128		6.4
Other products	381		1.2		376		1.1
	31,275		100.0	%	33,059		100.0	%
Synergy WorldWide:
Herbal products	$	10,005	38.1	%	$	9,797	40.0	%
Vitamin, mineral and other nutritional supplements	14,510		55.3		12,699		51.8
Personal care products	1,394		5.3		1,378		5.6
Other products	353		1.3		650		2.6
	26,262		100.0	%	24,524		100.0	%
Consolidated:
Herbal products	$	44,727	49.0	%	$	45,740	50.2	%
Vitamin, mineral and other nutritional supplements	40,843		44.8		39,032		42.8
Personal care products	4,308		4.7		4,517		5.0
Other products	1,354		1.5		1,813		2.0
	91,232		100.0	%	91,102		100.0	%

24

	Nine Months Ended September 30,
	2012				2011
NSP United States:
Herbal products	$	56,010	53.8	%	$	55,344	52.7	%
Vitamin, mineral and other nutritional supplements	43,061		41.4		43,204		41.1
Personal care products	2,976		2.9		3,328		3.2
Other products	2,006		1.9		3,185		3.0
	104,053		100.0	%	105,061		100.0	%
NSP International:
Herbal products	$	52,188	53.7	%	$	56,244	54.8	%
Vitamin, mineral and other nutritional supplements	37,191		38.3		37,631		36.6
Personal care products	6,660		6.8		7,473		7.3
Other products	1,148		1.2		1,313		1.3
	97,187		100.0	%	102,661		100.0	%
Synergy WorldWide:
Herbal products	$	29,982	39.5	%	$	27,428	40.3	%
Vitamin, mineral and other nutritional supplements	40,575		53.5		34,668		51.0
Personal care products	4,020		5.3		4,230		6.2
Other products	1,274		1.7		1,709		2.5
	75,851		100.0	%	68,035		100.0	%
Consolidated:
Herbal products	$	138,180	49.9	%	$	139,016	50.4	%
Vitamin, mineral and other nutritional supplements	120,827		43.6		115,503		41.9
Personal care products	13,656		4.9		15,031		5.5
Other products	4,428		1.6		6,207		2.2
	277,091		100.0	%	275,757		100.0	%

25

The following table summarizes our product lines by category:

Category	Description	Selected Representative Products
Herbal Products	We manufacture a wide selection of herbal products, some of which are sold in the form of capsules or tablets. These capsules or tablets contain herb powder or a combination of two or more herb powders. We also produce both single herbs and herb combinations in the form of liquid herbs and extracts. Liquid herbs are manufactured by concentrating herb constituents in a vegetable glycerin base. Extracts are created by dissolving powdered herbs into liquid solvents that separate the key elements of the herbs from the fibrous plant material.	Nature’s Sunshine Products (NSP U.S. and NSP International): ALJ®, Blood Pressurex, Cardio Assurance®, LBS II®, CleanStart® Synergy WorldWide: Core Greens®, Liquid Chlorophyll, Mistica®, Noni Plus
Vitamin, Mineral and Other
Nutritional Supplements	We manufacture a wide variety of single vitamins, some of which are sold in the form of chewable or non-chewable tablets. We manufacture several multiple vitamins and mineral supplements, including a line containing natural antioxidants, as well as energy and weight management products. Generally, mineral supplements are sold in the form of tablets; however, certain minerals are offered only in liquid form. We also manufacture several other products containing enzymes and pro-biotics which are sold in the form of capsules and amino-acid based products that are sold in the form of capsules or powders.	Nature’s Sunshine Products (NSP U.S. and NSP International): EverFlex®, Food Enzymes, Probiotic Eleven®, SmartMeal®, Solstic Energy®, Super Supplemental, Vitamin B Complex Synergy WorldWide: ProArgi-9 Plus®, SyneMax®, Vitazone®
Personal Care Products	We contract with independent manufacturers to supply a variety of personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste and skin cleanser.	Nature’s Sunshine Products (NSP U.S. and NSP International): EverFlex® Cream , Pau-D Arco Lotion, , Pro-G Yam® Cream, Tei-Fu® Lotion Synergy WorldWide: Bright Renewal Serum, Hydrating Toner, 5 in 1 Shampoo, Repair Complex
Other Products	We manufacture or contract with independent manufacturers to supply a variety of other products, including a variety of sales aids and other miscellaneous products.	Nature’s Sunshine Products (NSP U.S. and NSP International): Flower Essences, Lavender Oil, Peppermint Oil, Tei-Fu® Oil Synergy WorldWide: Lavender Oil, Massage Oil

LIQUIDITY AND CAPITAL RESOURCES

Our principal use of cash is to pay for operating expenses, including volume incentives, employee compensation and benefits, inventory and raw material purchases, capital assets and funding of international expansion. As of September 30, 2012, working capital was $73.5 million, compared to $57.3 million as of December 31, 2011.  At September 30, 2012, we had $72.5 million in cash and cash equivalents compared to $59.0 million as of December 31, 2011. Of our current cash and cash equivalents, $52.4 million was held in our foreign markets and may be subject to various withholding taxes and other restrictions related to repatriation, and $2.2 million in unrestricted short-term investments, which were available to be used along with our normal cash flows from operations.

26

Our net consolidated cash inflows (outflows) are as follows (in thousands):

	Nine Months Ended September 30,
	2012			2011
Operating activities	$	17,324		$	(4,120	)
Investing activities	(2,100		)	666
Financing activities	(2,043		)	10,372

For the nine months ended September 30, 2012, we generated cash from operating activities of $17.3 million compared to using cash of $4.1 million for the same period in 2011. Operating cash flows increased due to growth in our operating income compared to the nine months ended September 30, 2011, which included the one-time payment of $21.7 million related to the NutriPlus settlement, $14.7 million of which was recorded as contract termination costs and $7.0 million of previously accured royalties.

Capital expenditures for the nine months ended September 30, 2012 and 2011 were $5.6 million and $1.1 million, respectively. The current year increase in capital expenditures is related to the relocation of our corporate headquarters, upgrade of our Spanish Fork production facility and a new call center as well as the purchase of manufacturing and computer equipment.

During the nine months ended September 30, 2012, we had cash proceeds of $3.7 million primarily from the maturity of available-for-sale investments in Korea that were subsequently repatriated to the U.S. During the same period we used cash of $0.2 million to purchase available-for-sale investments.

During the nine months ended September 30, 2012, we used cash to make principal payments of $2.5 million on our term credit facility. The term credit facility is secured by the Company’s manufacturing facility in Spanish Fork, Utah.

The Company has a long-term revolving credit facility that allows us to borrow up to $15.0 million. As of September 30, 2012, no amounts were drawn under the credit facility.  We believe that, with this credit facility in place, our working capital requirements can be met for the foreseeable future with cash generated from operating activities, available cash and cash equivalents and draws on the credit facility. However, among other things, a prolonged economic downturn, a decrease in demand for our products, an unfavorable settlement of our unrecognized tax positions or non-income tax contingencies could adversely affect our long-term liquidity.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP and form the basis for the following discussion and analysis on critical accounting policies and estimates. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On a regular basis we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations. Management has discussed the development, selection and disclosure of these estimates with the Board of Directors and its Audit Committee.

A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2011. We believe the critical accounting policies and estimates described below reflect our more significant estimates and assumptions used in the preparation of our consolidated financial statements. The impact and any associated risks on our business that are related to these policies are also discussed throughout this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” where such policies affect reported and expected financial results.

Revenue Recognition

Net sales revenue and related volume incentive expenses are recorded when persuasive evidence of an arrangement exists, collectability is reasonably assured, the amount is fixed and determinable, and title and risk of loss have passed, generally when the merchandise has been delivered. The amount of the volume incentive is determined based upon the amount of qualifying purchases in a given month. It is necessary for us to make estimates about the timing of when merchandise has been delivered. These estimates are based upon our historical experience related to time in transit, and timing of when shipments occurred and shipping volumes. Amounts received for undelivered merchandise are recorded as deferred revenue. From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent

27

with industry standards within the country of operation. Payments to Managers and Distributors for sales incentives or rebates are recorded as a reduction of revenue. Payments for sales incentives and rebates are calculated monthly based upon qualifying sales. Membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. Prepaid event registration fees are deferred and recognized as revenues when the related event is held.

A reserve for product returns is recorded based upon historical experience.  We allow Managers and Distributors to return the unused portion of products within 90 days of purchase if they are not satisfied with the product.  In some of our markets, the requirements to return product are more or less restrictive based upon local statutes.

Accounts Receivable Allowances

Accounts receivable have been reduced by an allowance for amounts that may be uncollectible in the future. This estimated allowance is based primarily on the aging category, historical trends and management’s evaluation of the financial condition of the customer. This reserve is adjusted periodically as information about specific accounts becomes available.

Investments

Our available-for-sale investment portfolio is recorded at fair value and consists of various securities, such as state and municipal obligations, U.S. government security funds, short-term deposits and various equity securities. These investments are valued using (a) quoted prices for identical assets in active markets or (b) from significant inputs that are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset. Our trading portfolio is recorded at fair value and consists of various marketable securities that are valued using quoted prices in active markets.

For available-for-sale debt securities with unrealized losses, we perform an analysis to assess whether we intend to sell or whether it would be more likely than not required to sell the security before the expected recovery of the amortized cost basis. Where we intend to sell a security, or may be required to do so, the security’s decline in fair value is deemed to be other-than-temporary and the full amount of the unrealized loss is recorded within earnings as an impairment loss.

For all other debt securities that experience a decline in fair value that is determined to be other-than-temporary and not related to credit loss, we record a loss, net of any tax, in accumulated other comprehensive income (loss). The credit loss is recorded within earnings as an impairment loss when sold. Management judgment is involved in evaluating whether a decline in an investment’s fair value is other-than-temporary.

Regardless of our intent to sell a security, we perform additional analysis on all securities with unrealized losses to evaluate losses associated with the creditworthiness of the security. Credit losses are identified where we do not expect to receive cash flows sufficient to recover the amortized cost basis of a security.

For equity securities, when assessing whether a decline in fair value below our cost basis is other-than-temporary, we consider the fair market value of the security, the length of time and extent to which market value has been less than cost, the financial condition and near-term prospects of the issuer as well as specific events or circumstances that may influence the operations of the issuer, and our intent and ability to hold the investment for a sufficient time in order to enable recovery of our cost. New information and the passage of time can change these judgments. Where we have determined that we lack the intent and ability to hold an equity security to its expected recovery, the security’s decline in fair value is deemed to be other-than-temporary and is recorded within earnings as an impairment loss.

Inventories

Inventories are stated at the lower-of-cost-or-market, using the first-in, first-out method. The components of inventory cost include raw materials, labor and overhead. To estimate any necessary obsolescence or lower-of-cost-or-market adjustments, various assumptions are made in regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning and market conditions.

Self-Insurance Liabilities

Similar to other manufacturers and distributors of products that are ingested, we face an inherent risk of exposure to product liability claims in the event that, among other things, the use of our products results in injury to consumers due to tampering by unauthorized third parties or product contamination. We have historically had a very limited number of product claims or reports from individuals who have asserted that they have suffered adverse consequences as a result of using our products. These matters have historically been settled to our satisfaction and have not resulted in material payments. We have established a wholly owned captive

28

insurance company to provide us with product liability insurance coverage and have accrued a reserve that we believe is sufficient to cover probable and reasonable estimable liabilities related to product liability claims based upon our history. However, there can be no assurance that these estimates will prove to be sufficient, nor can there be any assurance that the ultimate outcome of any litigation for product liability will not have a material negative impact on our business prospects, financial position, results of operations or cash flows.

We self-insure for certain employee medical benefits. The recorded liabilities for self-insured risks are calculated using actuarial methods and are not discounted. The liabilities include amounts for actual claims and claims incurred but not reported. Actual experience, including claim frequency and severity as well as health care inflation, could result in actual liabilities being more or less than the amounts currently recorded.

Incentive Trip Accrual

We accrue expenses for incentive trips associated with our direct sales marketing program, which rewards independent Managers and Distributors with paid attendance at our conventions and meetings. Expenses associated with incentive trips are accrued over qualification periods as they are earned. We specifically analyze incentive trip accruals based on historical and current sales trends as well as contractual obligations when evaluating the adequacy of the incentive trip accrual. Actual results could generate liabilities more or less than the amounts recorded.

Impairment of Long-Lived Assets

We review our long-lived assets, such as property, plant and equipment and intangible assets for impairment when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We use an estimate of future undiscounted net cash flows of the related assets or groups of assets over their remaining lives in measuring whether the assets are recoverable. An impairment loss is calculated by determining the difference between the carrying values and the fair values of these assets. As of September 30, 2012 and December 31, 2011, we did not consider any of our long-lived assets to be impaired.

Contingencies

We are involved in certain legal proceedings. When a loss is considered probable in connection with litigation or non-income tax contingencies and when such loss can be reasonably estimated with a range, we record our best estimate within the range related to the contingency. If there is no best estimate, we record the minimum of the range. As additional information becomes available, we assess the potential liability related to the contingency and revise the estimates. Revision in estimates of the potential liabilities could materially affect our results of operations in the period of adjustment. Our contingencies are discussed in further detail in Note 10, “Commitments and Contingencies”, to the Notes of our Condensed Consolidated Financial Statements, of Item 1, Part 1 of this report.

Income Taxes

The Company’s income tax expense, deferred tax assets and liabilities and contingent reserves reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense.

Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating the Company’s ability to recover its deferred tax assets, management considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company develops assumptions including the amount of future state, federal and foreign pretax operating income, the reversal of temporary differences and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates the Company is using to manage the underlying businesses.

Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes that would have a material effect on the Company’s results of operations, cash flows or financial position.

The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized.

29

Share-Based Compensation

Our outstanding stock options include time-based stock options which vest over differing periods ranging from the date of issuance up to 48 months from the option grant date, performance-based stock options which vest upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options, and performance-based stock options which vest upon achieving cumulative annual net sales revenue growth targets over a rolling two-year period subject to the Company maintaining at least an eight percent operating income margin during the applicable period.

The Company recognizes all share-based payments to employees, including grants of employee stock options based on their grant-date fair values. The Company records compensation expense, net of estimated forfeitures, over the vesting period of the stock options based on the fair value of the stock options on the date of grant. Management considers several factors when estimating forfeitures, including types of awards, employee class and historical experience.

RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Note 1 to the Unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 of this report for information regarding recently issued accounting pronouncements.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this report may contain “forward-looking statements.”  Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities and Exchange Act.  All statements other than statements of historical fact are forward-looking statements.  Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements includes, among others, the following:

·our relationship with and our ability to influence the actions of our independent Managers and Distributors;

·our ability to attract and retain a sufficient number of independent Managers and Distributors;

·changes in laws and regulations regarding network marketing that may prohibit or restrict our ability to sell our products in new or existing markets;

·determinations regarding tax liabilities and required tax obligations in U.S. and foreign jurisdictions;

·our products and manufacturing activities are subject to extensive government regulations and restrictions;

·general economic conditions;

·an economic slowdown in the markets in which we do business could reduce consumer demand for our products;

·currency and exchange rate fluctuations could lower our revenue and net income;

·some of the markets in which we operate may become highly inflationary;

30

·some of the markets in which we operate have currency controls in place which restrict our ability to repatriate funds to the United States;

·the availability and integrity of raw materials could be compromised;

·significant legal disputes and adverse settlements;

·geopolitical issues and conflicts could adversely affect our business;

·our business is subject to the effects of adverse publicity and negative public perception;

·changes in taxation and transfer pricing could affect our operations;

·our business is subject to intellectual property risks;

·product and liability claims;

·changing consumer preferences and demands;

·a negative change in consumer perception of key ingredients or products;

·inventory obsolescence due to finite shelf lives and changing product demand;

·product concentration;

·system failures;

·unintended negative effects of distributor promotions or compensation plans;

·interruption or shutdown of our manufacturing facilities;

·changes in key management personnel; and

·the competitive nature of our business.

Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 under the heading “Risk Factors.”

Forward-looking statements in this report speak only as of the date hereof, and forward-looking statements in documents attached that are incorporated by reference speak only as of the date of those documents.  We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We conduct business in several countries and intend to continue to grow our international operations. Net sales revenue, operating income and net income are affected by fluctuations in currency exchange rates, interest rates and other uncertainties inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks associated with changes in social, political and economic conditions inherent in international operations, including changes in the laws and policies that govern international investment in countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment.

Foreign Currency Risk

During the nine months ended September 30, 2012, approximately 57.3 percent of our net sales revenue and approximately 54.8 percent of our operating expenses were realized outside of the United States. Inventory purchases are transacted primarily in U.S. dollars from vendors located in the United States. The local currency of each international subsidiary is generally the functional currency, while certain regions, including Russia and the Ukraine, are served by a U.S. subsidiary through third party entities, for

31

which all business is conducted in U.S. dollars. We conduct business in twenty-three different currencies with exchange rates that are not on a one-to-one relationship with the U.S. dollar. All revenues and expenses are translated at average exchange rates for the periods reported. Therefore, our operating results will be positively or negatively affected by a weakening or strengthening of the U.S. dollar in relation to another fluctuating currency. Given the uncertainty and diversity of exchange rate fluctuations, we cannot estimate the effect of these fluctuations on our future business, product pricing, results of operations or financial condition, but we have provided consolidated sensitivity analyses below of functional currency/reporting currency exchange rate risks. Changes in various currency exchange rates affect the relative prices at which we sell our products. We regularly monitor our foreign currency risks and periodically take measures to reduce the risk of foreign exchange rate fluctuations on our operating results. We do not use derivative instruments for hedging, trading or speculating on foreign exchange rate fluctuations.  Additional discussion of the impact on the effect of currency fluctuations has been included in our management’s discussion and analysis included in Part I, Item 2 of this report.

The following table sets forth a composite sensitivity analysis of our net sales revenue, costs and expenses and operating income in connection with strengthening of the U.S. dollar (our reporting currency) by 10%, 15% and 25% against every other fluctuating functional currency in which we conduct business.  We note that our individual net sales revenue, cost and expense components and our operating income were equally sensitive to increases in the strength of the U.S. dollar against every other fluctuating currency in which we conduct business.

Exchange rate sensitivity for the three months ended September 30, 2012 (dollar amounts in thousands)

			With Strengthening of U.S. Dollar by:
			10%					15%					25%
			($)			(%)		($)			(%)		($)			%)
Net sales revenue	$	91,232	$	(3,292	)	(3.6	)%	$	(4,724	)	(5.2	)%	$	(7,244	)	(7.9	)%
Cost and expenses
Cost of goods sold	17,713		(604		)	(3.4	)%	(867		)	(4.9	)%	(1,329		)	(7.5	)%
Volume incentives	33,155		(1,230		)	(3.7	)%	(1,765		)	(5.3	)%	(2,706		)	(8.2	)%
Selling, general and administrative	31,659		(1,069		)	(3.4	)%	(1,533		)	(4.8	)%	(2,350		)	(7.4	)%
Operating income	$	8,705	$	(389	)	(4.5	)%	$	(559	)	(6.4	)%	$	(859	)	(9.9	)%

Exchange rate sensitivity for the nine months ended September 30, 2012 (dollar amounts in thousands)

			With Strengthening of U.S. Dollar by:
			10%					15%					25%
			($)			(%)		($)			(%)		($)			%)
Net sales revenue	$	277,091	$	(9,644	)	(3.5	)%	$	(13,837	)	(5.0	)%	$	(21,217	)	(7.7	)%
Cost and expenses
Cost of goods sold	53,159		(1,761		)	(3.3	)%	(2,527		)	(4.8	)%	(3,875		)	(7.3	)%
Volume incentives	100,276		(3,558		)	(3.5	)%	(5,105		)	(5.1	)%	(7,828		)	(7.8	)%
Selling, general and administrative	95,466		(3,177		)	(3.3	)%	(4,558		)	(4.8	)%	$	(6,988	)	(7.3	)%
Operating income	$	28,190	$	(1,148	)	(4.1	)%	$	(1,647	)	(5.8	)%	$	(2,526	)	(9.0	)%

As noted above, certain of our operations, including Russia and the Ukraine, are served by a U.S. subsidiary through third-party entities, for which all business is conducted in U.S. dollars. Although changes in exchange rates between the U.S. dollar and the Russian ruble or the Ukrainian hryvnia do not result in currency fluctuations within our financial statements, a weakening or strengthening of the U.S. dollar in relation to these other currencies can significantly affect the prices of our products and the purchasing power of our independent Managers and Distributors within these markets.

The following table sets forth a composite sensitivity analysis of our financial instruments by those balance sheet line items that are subject to exchange rate risk, together with the total gain or loss from the strengthening of the U.S. dollar in relation to our various

32

fluctuating functional currencies.  The sensitivity of our assets and liabilities, taken by balance sheet line items, is somewhat less than the sensitivity of our operating income to increases in the strength of the U.S. dollar in relation to other fluctuating currencies in which we conduct business.

Exchange rate sensitivity of Balance Sheet as of September 30, 2012 (dollar amounts in thousands)

			With Strengthening of U.S. Dollar by:
			10%					15%					25%
			($)			(%)		($)			(%)		($)			(%)
Financial Instruments Included in Current Assets Subject to Exchange Rate Risk
Cash and cash equivalents	$	72,543	$	(4,556	)	(6.3	)%	$	(6,536	)	(9.0	)%	$	(10,022	)	(13.8	)%
Accounts receivable, net	10,003		(312		)	(3.1	)%	(448		)	(4.5	)%	(687		)	(6.9	)%
Financial Instruments Included in Current Liabilities Subject to Exchange Rate Risk
Accounts payable	5,710		(82		)	(1.4	)%	(117		)	(2.0	)%	(180		)	(3.2	)%
Net Financial Instruments Subject to Exchange Rate Risk	76,836		(4,786		)	(6.2	)%	(6,867		)	(8.9	)%	(10,529		)	(13.7	)%

The following table sets forth the local currencies other than the U.S. dollar in which our assets that are subject to exchange rate risk were denominated as of September 30, 2012, and exceeded $1 million upon translation into U.S. dollars.  None of our liabilities that are denominated in a local currency other than the U.S. dollar and that are subject to exchange rate risk exceeded $1 million upon translation into U.S. dollars. We use the spot exchange rate for translating balance sheet items from local currencies into our reporting currency.  The respective spot exchange rate for each such local currency meeting the foregoing thresholds is provided in the table as well.

Translation of the Balance Sheet Amounts Denominated in Local Currency as of September 30, 2012 (dollar amounts in thousands)

	Translated into U.S. Dollars		At Spot Exchange Rate per One U.S. Dollar as of September 30, 2012
Cash and Cash Equivalents
Japan (Yen)	4,418		77.9
Korea (Won)	$	3,765	1,125.5
Mexico (Peso)	3,214		12.9
Canada (Dollar)	2,921		1.0
European Markets (Euro)	2,588		0.8
Thailand (Baht)	2,406		31.1
Venezuela (Bolivar)	1,461		5.3
Colombia (Peso)	1,319		1,799.0
Indonesia (Rupiah)	1,192		9,596.9
Taiwan (Dollar)	1,114		29.5
Other	6,942		Varies
Total foreign denominated cash and cash equivalents	31,340
U.S. dollars held by foreign subsidiaries	21,065
Total cash and cash equivalents held by foreign subsidiaries	$	52,405
Accounts Receivable
Japan (Yen)	$	941	77.9
Other	2,494		Varies
Total	$	3,435

Finally, the following table sets forth the annual weighted average of fluctuating currency exchange rates of each of the local currencies per one U.S. dollar for each of the local currencies in which sales revenue exceeded $10.0 million during any of the two

33

periods presented.  We use the annual average exchange rate for translating items from the statement of operations from local currencies into our reporting currency.

Nine months ended September 30,	2012	2011
Canada (Dollar)	1.0	1.0
Japan (Yen)	79.3	80.5
Korea (Won)	1,141.8	1,096.2
Mexico (Peso)	13.2	12.0
Venezuela (Bolivar)	5.3	5.3

The local currency of the foreign subsidiaries is used as the functional currency, except for subsidiaries operating in highly inflationary economies or where the Company’s operations are served by a U.S. based subsidiary (for example, Russia and the Ukraine). The financial statements of foreign subsidiaries, where the local currency is the functional currency, are translated into U.S. dollars using exchange rates in effect at year-end for assets and liabilities and average exchange rates during each year for the results of operations. Adjustments resulting from translation of financial statements are reflected in accumulated other comprehensive loss, net of income taxes. Foreign currency transaction gains and losses are included in other income (expense) in the consolidated statements of operations.

The functional currency in highly inflationary economies is the U.S. dollar and transactions denominated in the local currency are re-measured as if the functional currency were the U.S. dollar. The re-measurement of local currencies into U.S. dollars creates translation adjustments, which are included in the consolidated statements of operations.  A country is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100 percent or more over a three-year period as well as other qualitative factors including historical inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors.  During the three and nine months ended September 30, 2012, Belarus and Venezuela were considered to be highly inflationary. During the three and nine months ended September 30, 2012, the Company’s Belarusian subsidiary’s net sales revenue represented approximately 1.6 percent and 1.5 percent of consolidated net sales revenue, respectively. During the three and nine months ended September 30, 2012, the Company’s Venezuelan subsidiary’s net sales revenue represented approximately 1.8 percent and 1.9 percent of consolidated net sales revenue, respectively. With the exceptions of Belarus and Venezuela, there were no other countries considered to have a highly inflationary economy during the three and nine months ended September 30, 2012.

Interest Rate Risk

The primary objectives of our investment activities are to preserve principal while maximizing yields without significantly increasing risk. These objectives are accomplished by purchasing investment grade securities. On September 30, 2012, we had investments of $2.2 million of which $0.7 million were municipal obligations, which carry an average fixed interest rate of 5.1 percent and mature over a three-year period. A hypothetical 1.0 percent change in interest rates would not have had a material effect on our liquidity, financial position or results of operations.

Item 4.    CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are designed to provide reasonable assurance that the information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosures. Our management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2012. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2012, at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the fiscal quarter ended September 30, 2012, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

34

PART II OTHER INFORMATION

Item 1.        LEGAL PROCEEDINGS

Please refer to Note 10 to the Unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 of this report, as well as our recent SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2011, for information regarding the status of certain legal proceedings that have been previously reported. There have been no material changes to the matters reported since those filings.

Item 1A.     RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the risks discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2011, which could materially affect our business or our consolidated financial statements, results of operations, and cash flows. Additional risks not currently known to us, or risks that we currently believe are not material, may also impair our business operations. We have identified the following additional risk factors since the filing of our Annual Report on Form 10-K for the year ended December 31, 2011:

Unintended negative effects of distributor promotions or compensation plans.

The payment of volume incentives is our most significant expense. These incentives include commissions, bonuses, and certain awards and prizes based on promotions and incentives. From time to time, we adjust our compensation plan to better manage these incentives as a percentage of net sales. We closely monitor the amount of volume incentives that are paid as a percentage of net sales, and may periodically adjust our compensation plan to prevent volume incentives from having a significant adverse effect on our earnings. In addition to the compensation plan, we frequently design and implement economic and non-economic incentives and promotions to motivate and reward our Distributors. There can be no assurance that changes to the compensation plan, product pricing, or promotions and incentives will be successful in achieving target levels of volume incentives as a percentage of net sales. Furthermore, such programs, promotions or incentives could result in unintended or unforeseen negative economic and non-economic consequences to our business.

Our manufacturing activity is subject to certain risks.

We manufacture approximately 85% of the products sold to our customers at our Spanish Fork, Utah location. As a result, we are dependent upon the uninterrupted and efficient operation of our manufacturing facility in Spanish Fork and our distribution facilities throughout the country. Our manufacturing facilities and distribution facilities are subject to the risk of catastrophic loss due to, among other things, fire, flood, terrorism or other natural or man-made disasters, as well as occurrence of significant equipment failures. If any of these facilities were to experience a catastrophic loss, it would be expected to disrupt our operations and could result in personal injury or property damage, damage relationships with our customers or result in large expenses to repair or replace the facilities or systems, as well as result in other liabilities and adverse impacts.

Item 2.        UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item 3.        DEFAULTS UPON SENIOR SECURITIES

None.

Item 4.        MINE SAFETY DISCLOSURES

Not applicable.

Item 5.        OTHER INFORMATION

None.

35

Item 6.        EXHIBITS

a)Index to Exhibits

Item No.	Exhibit
31.1(1)	Certification of Chief Executive Officer under SEC Rule 13a—14(a)/15d—14(a) promulgated under the Securities Exchange Act of 1934
31.2(1)	Certificate of Chief Financial Officer under SEC Rule 13a—14(a)/15d—14(a) promulgated under the Securities Exchange Act of 1934
32.1(1)	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350
32.2(1)	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350
101*	The following financial information from the quarterly report on Form 10-Q of Nature’s Sunshine Products, Inc. for the quarter ended September 30, 2012, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Cash Flows, and (v) Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text.

(1)           Filed currently herewith.

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NATURE’S SUNSHINE PRODUCTS, INC.
Date: November 5, 2012	/s/ Michael D. Dean
	Michael D. Dean, Chief Executive Officer
Date: November 5, 2012	/s/ Stephen M. Bunker
	Stephen M. Bunker, Executive Vice President, Chief Financial Officer and Treasurer

37

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Michael D. Dean, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Nature’s Sunshine Products, Inc. (“the registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2012	/s/ Michael D. Dean
	Michael D. Dean
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Stephen M. Bunker, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Nature’s Sunshine Products, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2012	/s/ Stephen M. Bunker
	Stephen M. Bunker
	Executive Vice President, Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Nature’s Sunshine Products, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael D. Dean, President and Chief Executive Officer of the Company, certify, pursuant to 18.U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2012	/s/ Michael D. Dean
	Michael D. Dean
	Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Nature’s Sunshine Products, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen M. Bunker, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18.U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2012	/s/ Stephen M. Bunker
	Stephen M. Bunker
	Executive Vice President, Chief Financial Officer and Treasurer

XML

Net Income Per Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net Income Per Share
Net income (loss)	$ 6,370	$ (2,256)	$ 20,884	$ 9,980
Basic weighted average shares outstanding	15,628	15,562	15,603	15,544
Basic net income per common share:
Net income (loss) per common share (in dollars per share)	$ 0.41	$ (0.14)	$ 1.34	$ 0.64
Diluted weighted average shares outstanding
Basic weighted average shares outstanding	15,628	15,562	15,603	15,544
Weighted average stock grants outstanding	343		314	130
Diluted weighted average shares outstanding	15,971	15,562	15,917	15,674
Diluted net income per common share:
Net income (loss) per common share (in dollars per share)	$ 0.40	$ (0.14)	$ 1.31	$ 0.64
Potentially dilutive shares excluded from diluted per share amounts:
Stock options (in shares)	96		96	661
Potentially anti-dilutive shares excluded from diluted per share amounts:
Stock options (in shares)	167	1,379	249	202

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2012

Segment Information

Schedule of reportable business segment information

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Net sales revenue:
Nature’s Sunshine Products:
United States	$	33,695		$	33,519		$	104,053		$	105,061
International	31,275			33,059			97,187			102,661
	64,970			66,578			201,240			207,722
Synergy WorldWide	26,262			24,524			75,851			68,035
Total net sales revenue	91,232			91,102			277,091			275,757
Operating expenses:
Nature’s Sunshine Products:
United States	31,001			31,176			94,230			95,257
International	27,826			43,151			85,860			108,852
	58,827			74,327			180,090			204,109
Synergy WorldWide	23,700			21,880			68,811			61,080
Total operating expenses	82,527			96,207			248,901			265,189
Operating income (loss):
Nature’s Sunshine Products:
United States	2,694			2,343			9,823			9,804
International	3,449			(10,092		)	11,327			(6,191		)
	6,143			(7,749		)	21,150			3,613
Synergy WorldWide	2,562			2,644			7,040			6,955
Total operating income (loss)	8,705			(5,105		)	28,190			10,568
Other income (expense), net	(214		)	1,204			(159		)	1,049
Income (loss) before provision for income taxes	$	8,491		$	(3,901	)	$	28,031		$	11,617

Schedule of consolidated net sales revenue by geographical locations

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Net sales revenue:
United States	$	38,243	$	38,885	$	118,390	$	120,868
Other	52,989		52,217		158,701		154,889
	$	91,232	$	91,102	$	277,091	$	275,757

Schedule of revenue generated by each of the entity's product lines

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
NSP United States:
Herbal products	$	17,809	$	17,441	$	56,010	$	55,344
Vitamin, mineral and other nutritional supplements	14,296		14,280		43,061		43,204
Personal care products	970		1,011		2,976		3,328
Other products	620		787		2,006		3,185
	33,695		33,519		104,053		105,061
NSP International:
Herbal products	$	16,913	$	18,502	$	52,188	$	56,244
Vitamin, mineral and other nutritional supplements	12,037		12,053		37,191		37,631
Personal care products	1,944		2,128		6,660		7,473
Other products	381		376		1,148		1,313
	31,275		33,059		97,187		102,661
Synergy WorldWide:
Herbal products	$	10,005	$	9,797	$	29,982	$	27,428
Vitamin, mineral and other nutritional supplements	14,510		12,699		40,575		34,668
Personal care products	1,394		1,378		4,020		4,230
Other products	353		650		1,274		1,709
	26,262		24,524		75,851		68,035
	$	91,232	$	91,102	$	277,091	$	275,757

Schedule of consolidated property, plant and equipment by geographical locations

	September 30, 2012		December 31, 2011
Property, plant and equipment:
United States	$	20,951	$	18,119
Venezuela	3,636		3,939
Other	3,388		3,079
Total property, plant and equipment	$	27,975	$	25,137

XML

Commitments and Contingencies (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Value-added tax assessments and other civil litigation
Commitments and contingencies
Future payments related to value-added tax assessments and other civil litigation, minimum	$ 0
Future payments related to value-added tax assessments and other civil litigation, maximum	1,000
Minimum number of claims that the Company's insurance coverage may not be sufficient to cover	1
Non-income Tax Contingencies
Commitments and contingencies
Accrued liabilities related to non-income tax contingencies	$ 6,580	$ 6,921

XML

Inventories

9 Months Ended

Sep. 30, 2012

Inventories

Inventories

(2)Inventories

Inventories consist of the following:

	September 30,		December 31,
	2012		2011
Raw Materials	$	13,814	$	12,992
Work in Progress	931		1,230
Finished Goods	28,910		27,389
	$	43,655	$	41,611

XML

Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Intangible assets
Net amount	$ 1,040		$ 1,040		$ 1,151
Product formulations
Intangible assets
Gross carrying amount	1,763		1,763		1,763
Accumulated amortization	723		723		612
Net amount	1,040		1,040		1,151
Amortization expense for intangible assets	37	37	111	111
Estimated amortization expense
Fiscal year, one	149		149
Fiscal year, two	149		149
Fiscal year, three	149		149
Fiscal year, four	149		149
Fiscal year, five	$ 149		$ 149
Minimum | Product formulations
Intangible assets
Estimated useful lives			9 years
Maximum | Product formulations
Intangible assets
Estimated useful lives			15 years

XML

Inventories (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Inventories
Raw Materials	$ 13,814	$ 12,992
Work in Progress	931	1,230
Finished Goods	28,910	27,389
Total	$ 43,655	$ 41,611

XML

Investments (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Investment securities
Amortized Cost	$ 1,926		$ 5,477
Gross Unrealized Gains	276		210
Gross Unrealized Losses	(10)		(10)
Fair value	2,192		5,677
Proceeds from the maturities and sales of available-for-sale securities	3,689	5,650
Municipal obligations
Investment securities
Amortized Cost	709		1,158
Gross Unrealized Gains	36		51
Fair value	745		1,209
Municipal obligations | Maximum
Investment securities
Maturity period	3 years
U.S. government security funds
Investment securities
Amortized Cost	990		988
Gross Unrealized Losses	(4)		(5)
Fair value	986		983
Short-term deposits
Investment securities
Amortized Cost			3,104
Fair value			3,104
Equity securities
Investment securities
Amortized Cost	227		227
Gross Unrealized Gains	240		159
Gross Unrealized Losses	(6)		(5)
Fair value	$ 461		$ 381

XML

Investments (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Trading securities portfolio
Trading securities portfolio	$ 1,317		$ 1,317		$ 1,429
Losses		121		46
Gains	$ 44		$ 104

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2012

Basis of Presentation

Basis of Presentation

(1)Basis of Presentation

Nature’s Sunshine Products, Inc., together with its subsidiaries (hereinafter referred to collectively as the “Company”), is a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. The Company is a Utah corporation with its principal place of business in Lehi, Utah, and sells its products to a sales force of independent Managers, Distributors and customers who use the products themselves or resell them to other Distributors or customers. The formulation, manufacturing, packaging, labeling, advertising, distribution and sale of each of the Company’s major product groups are subject to regulation by one or more governmental agencies.

The Company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, Indonesia, Ireland, Japan, Kazakhstan, Latvia, Lithuania, Malaysia, Mexico, Moldova, Mongolia, the Netherlands, Nicaragua, Norway, Panama, Peru, the Philippines, Poland, Russia, Singapore, South Korea, Spain, Sweden, Taiwan, Thailand, the Ukraine, the United Kingdom, the United States, Venezuela and Vietnam. The Company also exports its products to several other countries, including Argentina, Australia, Chile, Israel and New Zealand.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries.  All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial information as of September 30, 2012, and for the three month and nine month periods ended September 30, 2012 and 2011.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year ending December 31, 2012.

It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Classification of Belarus as a Highly Inflationary Economy and Devaluation of Its Currency

As of June 30, 2012, Belarus was designated as a highly inflationary economy. Historically, the U.S. dollar has been our functional currency for this market. As a result, there were no resulting gains or losses from a re-measurement of the financial statements using official rates of the Company’s Belarusian subsidiary.  However, as a result of the weakening of the Belarusian ruble, the purchasing power of our Distributors in this market has become diminished. During the three and nine months ended September 30, 2012, the Company’s Belarusian subsidiary’s net sales revenue represented approximately 1.6 percent and 1.5 percent of consolidated net sales revenue, respectively. The Company’s total and net assets related to Belarus as of September 30, 2012 and December 31, 2011 were insignificant.

Contract Termination Costs

In 1999 and 2000, the Company and NutriPlus LLC (“NutriPlus”) entered into an Asset Purchase Agreement and subsequent Settlement Agreement (together the “Purchase Agreement”) under which the Company acquired certain assets in order to establish its Russian business, and NutriPlus acquired rights to receive certain royalty payments from the Company expressed as a percentage of the Company’s net sales in its Russian business.

On July 8, 2011, the Company and NutriPlus entered into a settlement agreement, in which the Company agreed to pay NutriPlus $21,700 for the release of all past and future royalty obligations.  Of the $21,700, the Company applied $6,950 toward previously accrued and expensed but unpaid royalties, and $14,750 in exchange for the contract termination and extinguishment of future royalty obligations.

XML

Long-Term Debt (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2012	Dec. 31, 2011	Aug. 09, 2011
Long term debt
Less current installments	$ (3,334)	$ (3,296)
Long-term debt	3,392	5,894
Revolving Credit agreement
Long term debt
Maximum borrowing capacity			15,000
Variable rate basis	LIBOR
Margin on variable rate (as a percent)	1.25%
Annual commitment fee (as a percent)	0.25%
Remaining borrowing capacity	15,000	15,000
Term loan
Long term debt
Face amount			10,000
Variable rate basis	LIBOR
Margin on variable rate (as a percent)	1.25%
Interest rate at period end (as a percent)	1.50%
Monthly installments, including interest	285	285
Long-term debt	$ 6,726	$ 9,190

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Current Assets:
Cash and cash equivalents	$ 72,543	$ 58,969
Accounts receivable, net of allowance for doubtful accounts of $607 and $647, respectively	10,003	9,868
Investments available for sale	2,192	5,677
Inventories	43,655	41,611
Deferred income tax assets	4,668	4,395
Prepaid expenses and other	5,946	4,583
Total current assets	139,007	125,103
Property, plant and equipment, net	27,975	25,137
Investment securities	1,317	1,429
Intangible assets, net	1,040	1,151
Deferred income tax assets	16,610	16,576
Other assets	6,619	6,415
Total Assets	192,568	175,811
Current Liabilities:
Accounts payable	5,710	5,980
Accrued volume incentives	19,802	19,326
Accrued liabilities	27,224	27,938
Deferred revenue	3,005	2,603
Current installments of long-term debt	3,334	3,296
Income taxes payable	4,468	8,655
Total current liabilities	63,543	67,798
Liability related to unrecognized tax benefits	9,772	10,426
Long-term debt	3,392	5,894
Deferred compensation payable	1,317	1,429
Other liabilities	2,696	2,826
Total long-term liabilities	17,177	20,575
Commitments and Contingencies (Note 10)
Shareholders' Equity:
Common stock, no par value; 50,000 shares authorized, 15,761 and 15,569 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively	75,612	71,628
Retained earnings	45,203	25,879
Accumulated other comprehensive loss	(8,967)	(10,069)
Total shareholders' equity	111,848	87,438
Total Liabilities and Shareholders' Equity	$ 192,568	$ 175,811

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net income (loss)	$ 6,370	$ (2,256)	$ 20,884	$ 9,980
Foreign currency translation gain (loss) (net of tax)	1,416	(1,734)	1,061	(249)
Net unrealized gains (losses) on investment securities (net of tax)	20	(40)	41	(18)
Total comprehensive income (loss)	$ 7,806	$ (4,030)	$ 21,986	$ 9,713

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012 itme	Sep. 30, 2011	Dec. 31, 2011
Segment information
Number of business segments				3
Net sales revenue:
Total net sales revenue		$ 91,232	$ 91,102	$ 277,091	$ 275,757
Operating expenses:
Total operating expenses		82,527	96,207	248,901	265,189
Operating income (loss):
Total operating income (loss)		8,705	(5,105)	28,190	10,568
Other income (expense), net		(214)	1,204	(159)	1,049
Income (loss) before provision for income taxes		8,491	(3,901)	28,031	11,617
Contract termination costs	14,750		14,750		14,750
Property, plant and equipment:
Total property, plant and equipment		27,975		27,975		25,137
United States
Net sales revenue:
Total net sales revenue		38,243	38,885	118,390	120,868
Property, plant and equipment:
Total property, plant and equipment		20,951		20,951		18,119
International
Net sales revenue:
Total net sales revenue		52,989	52,217	158,701	154,889
Other
Property, plant and equipment:
Total property, plant and equipment		3,388		3,388		3,079
Venezuela
Property, plant and equipment:
Total property, plant and equipment		3,636		3,636		3,939
Nature's Sunshine Products
Segment information
Number of business segments				2
Net sales revenue:
Total net sales revenue		64,970	66,578	201,240	207,722
Operating expenses:
Total operating expenses		58,827	74,327	180,090	204,109
Operating income (loss):
Total operating income (loss)		6,143	(7,749)	21,150	3,613
Nature's Sunshine Products | United States
Net sales revenue:
Total net sales revenue		33,695	33,519	104,053	105,061
Operating expenses:
Total operating expenses		31,001	31,176	94,230	95,257
Operating income (loss):
Total operating income (loss)		2,694	2,343	9,823	9,804
Nature's Sunshine Products | United States | Herbal products
Net sales revenue:
Total net sales revenue		17,809	17,441	56,010	55,344
Nature's Sunshine Products | United States | Vitamin, mineral and other nutritional supplements
Net sales revenue:
Total net sales revenue		14,296	14,280	43,061	43,204
Nature's Sunshine Products | United States | Personal care products
Net sales revenue:
Total net sales revenue		970	1,011	2,976	3,328
Nature's Sunshine Products | United States | Other products
Net sales revenue:
Total net sales revenue		620	787	2,006	3,185
Nature's Sunshine Products | International
Net sales revenue:
Total net sales revenue		31,275	33,059	97,187	102,661
Operating expenses:
Total operating expenses		27,826	43,151	85,860	108,852
Operating income (loss):
Total operating income (loss)		3,449	(10,092)	11,327	(6,191)
Contract termination costs			14,750		14,750
Nature's Sunshine Products | International | Herbal products
Net sales revenue:
Total net sales revenue		16,913	18,502	52,188	56,244
Nature's Sunshine Products | International | Vitamin, mineral and other nutritional supplements
Net sales revenue:
Total net sales revenue		12,037	12,053	37,191	37,631
Nature's Sunshine Products | International | Personal care products
Net sales revenue:
Total net sales revenue		1,944	2,128	6,660	7,473
Nature's Sunshine Products | International | Other products
Net sales revenue:
Total net sales revenue		381	376	1,148	1,313
Synergy WorldWide
Net sales revenue:
Total net sales revenue		26,262	24,524	75,851	68,035
Operating expenses:
Total operating expenses		23,700	21,880	68,811	61,080
Operating income (loss):
Total operating income (loss)		2,562	2,644	7,040	6,955
Synergy WorldWide | Herbal products
Net sales revenue:
Total net sales revenue		10,005	9,797	29,982	27,428
Synergy WorldWide | Vitamin, mineral and other nutritional supplements
Net sales revenue:
Total net sales revenue		14,510	12,699	40,575	34,668
Synergy WorldWide | Personal care products
Net sales revenue:
Total net sales revenue		1,394	1,378	4,020	4,230
Synergy WorldWide | Other products
Net sales revenue:
Total net sales revenue		$ 353	$ 650	$ 1,274	$ 1,709

XML

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2012

Long-Term Debt

Schedule of long-term debt

	September 30,			December 31,
	2012			2011
Term loan due in monthly installments of approximately $285, including interest, secured by real estate	$	6,726		$	9,190
Less current installments	(3,334		)	(3,296		)
Long-term debt	$	3,392		$	5,894

XML

Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Income Taxes
Provision for income taxes, as a percentage of income (loss) before income taxes	25.00%	(42.20%)	25.50%	14.10%
U.S. federal statutory rate (as a percent)	35.00%	35.00%	35.00%	35.00%
Utilization of foreign tax credits (as a percent)	(6.80%)		(6.50%)
Addition to net favorable items (as a percent)	(4.20%)		(4.00%)
Contract termination costs (as a percent)				(9.50%)
Addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (as a percent)		(3.90%)		(11.50%)
Accrued amount related to uncertain tax positions	$ 9,772		$ 9,772		$ 10,426

XML

Capital Transactions (Tables)

9 Months Ended

Sep. 30, 2012

Capital Transactions

Schedule of stock option activity

	Number of Shares		Weighted Average Exercise Price Per Share
Options outstanding at December 31, 2011	1,374		$	9.88
Granted	681		15.11
Expired	(6	)	8.59
Exercised	(191	)	10.34
Options outstanding at September 30, 2012	1,858		11.75

Schedule of weighted-average assumptions using Black-Scholes option-pricing model for estimating fair value of each option granted

	2012
Expected life (in years)	4.0 to 6.0
Risk-free interest rate	0.3 to 0.9
Expected volatility	58.5 to 66.0
Dividend yield	0.0 to 1.3

Schedule of restricted stock unit activity

	Number of Shares	Weighted Average Grant Date Fair Value
Units outstanding at December 31, 2011	—	$	—
Granted	18	12.07
Vested	—	—
Forfeited	—	—
Units outstanding at September 30, 2012	18	12.07

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 20,884	$ 9,980
Adjustments to reconcile net income to net cash provided by (used in) by operating activities:
Provision for doubtful accounts	39	(101)
Depreciation and amortization	3,028	3,204
Share-based compensation expense	2,001	1,917
Loss on sale of property and equipment	23	14
Deferred income taxes	(307)	(4,419)
Amortization of bond discount	3	13
Purchase of trading investment securities	(60)	(59)
Proceeds from sale of trading investment securities	268	338
Realized and unrealized (gains) losses on investments	(63)	25
Foreign exchange losses	856	106
Changes in assets and liabilities:
Accounts receivable	(429)	(5,691)
Inventories	(1,926)	(2,313)
Prepaid expenses and other current assets	(1,021)	607
Other assets	(148)	(2,155)
Accounts payable	(361)	428
Accrued volume incentives	386	1,224
Accrued liabilities	(1,264)	(4,554)
Deferred revenue	403	(343)
Income taxes payable	(4,222)	848
Liability related to unrecognized tax benefits	(654)	(2,834)
Deferred compensation payable	(112)	(355)
Net cash provided by (used in) operating activities	17,324	(4,120)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(5,617)	(1,117)
Proceeds from sale of property, plant and equipment	25
Proceeds from maturity and sale of investments available for sale	3,689	5,650
Purchase of investments available for sale	(197)	(3,867)
Net cash provided by (used in) investing activities	(2,100)	666
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of long-term debt		10,000
Principal payments of long-term debt	(2,465)
Dividends paid	(1,560)
Proceeds from the exercise of stock options	1,982	372
Net cash provided by (used in) financing activities	(2,043)	10,372
Effect of exchange rates on cash and cash equivalents	393	(419)
Net increase in cash and cash equivalents	13,574	6,499
Cash and cash equivalents at the beginning of the period	58,969	47,604
Cash and cash equivalents at the end of the period	72,543	54,103
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes	12,694	7,851
Cash paid for interest	$ 97

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 607	$ 647
Common stock, shares authorized	50,000	50,000
Common stock, shares issued	15,761	15,569
Common stock, shares outstanding	15,761	15,569

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2012

Commitments and Contingencies

Commitments and Contingencies

(10)Commitments and Contingencies

Legal Proceedings

The Company is party to various legal proceedings related to value-added tax assessments and other civil litigation. Management cannot predict the ultimate outcome of these proceedings, individually or in the aggregate, or their resulting effect on the Company’s business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Therefore, no provision for losses has been provided. The Company believes future payments related to these matters could range from $0 to approximately $1,000. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the business, financial position, results of operations or cash flows for the periods in which the ruling occurs and/or future periods. The Company maintains directors’ and officers’ liability, product liability, general liability and excess liability insurance coverage. However, no assurances can be given that such insurance will continue to be available at an acceptable cost to the Company, that such coverage will be sufficient to cover one or more large claims, or that the insurers will not successfully disclaim coverage as to a pending or future claim.

Non-income Tax Contingencies

The Company has reserved for certain foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management’s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. The Company provides provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes. As of September 30, 2012 and December 31, 2011, accrued liabilities include $6,580 and $6,921, respectively, related to non-income tax contingencies. While management believes that the assumptions and estimates used to determine this liability are reasonable, the ultimate outcome of those matters cannot presently be determined. The Company is not able at this time to predict the ultimate outcomes of those matters or to estimate the effect of the ultimate outcomes, if greater than the amounts accrued, would have on the financial condition, results of operations or cash flows of the Company.

Government Regulations

The Company is subject to governmental regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and to the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determinations that either the Company or the Company’s Distributors are not in compliance with existing statutes, laws, rules or regulations could potentially have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations, or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance, in all material respects, with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2012	Oct. 31, 2012
Document and Entity Information
Entity Registrant Name	NATURES SUNSHINE PRODUCTS INC
Entity Central Index Key	0000275053
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		15,763,560
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2012

Fair Value Measurements

Fair Value Measurements

(11)Fair Value Measurements

The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of September 30, 2012:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	745	$	—	$	745
U.S. government security funds	986		—		—		986
Equity securities	461		—		—		461
Investment securities	1,317		—		—		1,317
Total assets measured at fair value on a recurring basis	$	2,764	$	745	$	—	$	3,509

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of December 31, 2011:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	1,209	$	—	$	1,209
U.S. government security funds	983		—		—		983
Short-term deposits	—		3,104		—		3,104
Equity securities	381		—		—		381
Investment securities	1,429		—		—		1,429
Total assets measured at fair value on a recurring basis	$	2,793	$	4,313	$	—	$	7,106

Investments available for sale — The majority of the Company’s investment portfolio consists of various securities, such as state and municipal obligations, U.S. government security funds, short-term deposits and various equity securities.  The Level 1 securities are valued using quoted prices for identical assets in active markets including equity securities and U.S. government treasuries.  The Level 2 securities include investments in state and municipal bonds whereby all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset.

Investment securities — The majority of the Company’s trading portfolio consists of various marketable securities that are using quoted prices in active markets.

For the nine months ended September 30, 2012 and for the year ended December 31, 2011, there were no fair value measurements using the significant unobservable inputs (Level 3).

The carrying amounts reflected on the consolidated balance sheet for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying amount reflected in the consolidated balance sheet for long-term debt approximates fair value due to the interest rate on the debt being variable based on current market rates. During the three months ended September 30, 2012 and 2011, the Company did not have any write-offs related to the re-measurement of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net sales revenue (net of the rebate portion of volume incentives of $10,460 and $10,877, for the three months ended and $32,746 and $33,815 for the nine months ended, respectively)	$ 91,232	$ 91,102	$ 277,091	$ 275,757
Cost and expenses:
Cost of goods sold	17,713	16,879	53,159	52,560
Volume incentives	33,155	32,733	100,276	100,421
Selling, general and administrative	31,659	31,845	95,466	97,458
Contract termination costs		14,750		14,750
Total cost and expenses	82,527	96,207	248,901	265,189
Operating income (loss)	8,705	(5,105)	28,190	10,568
Other income (expense), net	(214)	1,204	(159)	1,049
Income (loss) before provision for income taxes	8,491	(3,901)	28,031	11,617
Provision (benefit) for income taxes	2,121	(1,645)	7,147	1,637
Net income (loss)	$ 6,370	$ (2,256)	$ 20,884	$ 9,980
Basic:
Net income (loss) per common share (in dollars per share)	$ 0.41	$ (0.14)	$ 1.34	$ 0.64
Diluted:
Net income (loss) per common share (in dollars per share)	$ 0.40	$ (0.14)	$ 1.31	$ 0.64
Weighted average basic common shares outstanding (in shares)	15,628	15,562	15,603	15,544
Weighted average diluted common shares outstanding (in shares)	15,971	15,562	15,917	15,674
Dividends declared per common share (in dollars per share)	$ 0.05		$ 0.10

XML

Long-Term Debt

9 Months Ended

Sep. 30, 2012

Long-Term Debt

Long-Term Debt

(5)Long-Term Debt

On August 9, 2011, the Company entered into a Revolving Credit Agreement with Wells Fargo Bank, N. A., that permits the Company to borrow up to $15,000 through August 9, 2013, bearing interest at LIBOR plus 1.25 percent. The Company must pay an annual commitment fee of 0.25 percent on the unused portion of the commitment. At September 30, 2012 and December 31, 2011, the Company had $15,000 available under this facility.

A term loan of $10,000 was obtained in conjunction with the Revolving Credit Agreement with Wells Fargo Bank, N. A., and has a maturity date of August 9, 2014, a variable interest rate of LIBOR plus 1.25 percent (1.50 percent as of September 30, 2012) and monthly amortization of principal. The term loan is collateralized by the Company’s manufacturing facility in Spanish Fork, Utah.

Long-term debt at September 30, 2012 and December 31, 2011 consists of the following:

	September 30,			December 31,
	2012			2011
Term loan due in monthly installments of approximately $285, including interest, secured by real estate	$	6,726		$	9,190
Less current installments	(3,334		)	(3,296		)
Long-term debt	$	3,392		$	5,894

The Revolving Credit Agreement contains restrictions on liquidity, leverage levels, minimum net income and consecutive quarterly net losses. In addition, the agreements restrict capital expenditures, lease expenditures, other indebtedness, liens on assets, guaranties, loans and advances, and the merger, consolidation and transfer of assets except in the ordinary course of business.  The Company is currently in compliance with these debt covenants.

XML

Investments

9 Months Ended

Sep. 30, 2012

Investments

Investments

(4)Investments

The amortized cost and estimated fair values of available-for-sale securities by investment category are as follows:

As of September 30, 2012	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	709	$	36	$	—		$	745
U.S. government securities funds	990		—		(4		)	986
Equity securities	227		240		(6		)	461
Total short-term investment securities	$	1,926	$	276	$	(10	)	$	2,192

As of December 31, 2011	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	1,158	$	51	$	—		$	1,209
U.S. government securities funds	988		—		(5		)	983
Short-term deposits	3,104		—		—			3,104
Equity securities	227		159		(5		)	381
Total short-term investment securities	$	5,477	$	210	$	(10	)	$	5,677

The municipal obligations held at a fair value of $745 at September 30, 2012 all mature in less than three years.

During the nine month periods ended September 30, 2012 and 2011, the proceeds from the maturities and sales of available-for-sale securities were $3,689 and $5,650, respectively. There were no gross realized gains (losses) on sales of available-for-sale securities (net of tax) for the nine month periods ended September 30, 2012 and 2011, respectively.

The Company’s trading securities portfolio totaled $1,317 at September 30, 2012 and $1,429 at December 31, 2011, and generated gains of $44 and losses of $121 for the three months ended September 30, 2012 and 2011, respectively and generated gains of $104 and losses of $46 for the nine months ended September 30, 2012 and 2011, respectively.

As of September 30, 2012 and December 31, 2011, the Company had unrealized losses of $4 and $5, respectively, in its U.S. government securities funds. These losses are due to the interest rate sensitivity of the U.S. government securities funds.

XML

Net Income Per Share (Tables)

9 Months Ended

Sep. 30, 2012

Net Income Per Share

Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS

	Three Months Ended September 30,					Nine Months Ended September 30,
	2012		2011			2012		2011
Net income (loss)	$	6,370	$	(2,256	)	$	20,884	$	9,980
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Basic net income per common share:
Net income (loss) per common share	$	0.41	$	(0.14	)	$	1.34	$	0.64
Diluted weighted average shares outstanding
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Weighted average stock grants outstanding	343		—			314		130
Diluted weighted average shares outstanding	15,971		15,562			15,917		15,674
Diluted net income per common share:
Net income (loss) per common share	$	0.40	$	(0.14	)	$	1.31	$	0.64
Potentially dilutive shares excluded from diluted per share amounts:
Stock options	96		—			96		661
Potentially anti-dilutive shares excluded from diluted per share amounts:
Stock options	167		1,379			249		202

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2012

Basis of Presentation

Basis of Presentation

Basis of Presentation

Nature’s Sunshine Products, Inc., together with its subsidiaries (hereinafter referred to collectively as the “Company”), is a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. The Company is a Utah corporation with its principal place of business in Lehi, Utah, and sells its products to a sales force of independent Managers, Distributors and customers who use the products themselves or resell them to other Distributors or customers. The formulation, manufacturing, packaging, labeling, advertising, distribution and sale of each of the Company’s major product groups are subject to regulation by one or more governmental agencies.

The Company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, Indonesia, Ireland, Japan, Kazakhstan, Latvia, Lithuania, Malaysia, Mexico, Moldova, Mongolia, the Netherlands, Nicaragua, Norway, Panama, Peru, the Philippines, Poland, Russia, Singapore, South Korea, Spain, Sweden, Taiwan, Thailand, the Ukraine, the United Kingdom, the United States, Venezuela and Vietnam. The Company also exports its products to several other countries, including Argentina, Australia, Chile, Israel and New Zealand.

Principles of Consolidation

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries.  All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial information as of September 30, 2012, and for the three month and nine month periods ended September 30, 2012 and 2011.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year ending December 31, 2012.

It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Classification of Belarus as a Highly Inflationary Economy and Devaluation of Its Currency

Classification of Belarus as a Highly Inflationary Economy and Devaluation of Its Currency

As of June 30, 2012, Belarus was designated as a highly inflationary economy. Historically, the U.S. dollar has been our functional currency for this market. As a result, there were no resulting gains or losses from a re-measurement of the financial statements using official rates of the Company’s Belarusian subsidiary.  However, as a result of the weakening of the Belarusian ruble, the purchasing power of our Distributors in this market has become diminished. During the three and nine months ended September 30, 2012, the Company’s Belarusian subsidiary’s net sales revenue represented approximately 1.6 percent and 1.5 percent of consolidated net sales revenue, respectively. The Company’s total and net assets related to Belarus as of September 30, 2012 and December 31, 2011 were insignificant.

Contract Termination Costs

Contract Termination Costs

In 1999 and 2000, the Company and NutriPlus LLC (“NutriPlus”) entered into an Asset Purchase Agreement and subsequent Settlement Agreement (together the “Purchase Agreement”) under which the Company acquired certain assets in order to establish its Russian business, and NutriPlus acquired rights to receive certain royalty payments from the Company expressed as a percentage of the Company’s net sales in its Russian business.

On July 8, 2011, the Company and NutriPlus entered into a settlement agreement, in which the Company agreed to pay NutriPlus $21,700 for the release of all past and future royalty obligations.  Of the $21,700, the Company applied $6,950 toward previously accrued and expensed but unpaid royalties, and $14,750 in exchange for the contract termination and extinguishment of future royalty obligations.

XML

Segment Information

9 Months Ended

Sep. 30, 2012

Segment Information

Segment Information

(8)Segment Information

The Company has three business segments. These business segments are components of the Company for which separate information is available that is evaluated regularly by the chief executive officer in deciding how to allocate resources and in assessing relative performance.

The Company has two business segments that operate under the Nature’s Sunshine Products brand and are divided based on their geographic operations in the United States (NSP United States) and in countries outside the United States (NSP International). The Company’s third business segment operates under the Synergy WorldWide brand, which distributes its products through different marketing and distributor compensation plans and products with formulations that are sufficiently different from those of NSP United States and NSP International to warrant accounting for these operations as a separate business segment. Net sales revenues and operating income (loss) for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer.

Reportable business segment information is as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Net sales revenue:
Nature’s Sunshine Products:
United States	$	33,695		$	33,519		$	104,053		$	105,061
International	31,275			33,059			97,187			102,661
	64,970			66,578			201,240			207,722
Synergy WorldWide	26,262			24,524			75,851			68,035
Total net sales revenue	91,232			91,102			277,091			275,757
Operating expenses:
Nature’s Sunshine Products:
United States	31,001			31,176			94,230			95,257
International	27,826			43,151			85,860			108,852
	58,827			74,327			180,090			204,109
Synergy WorldWide	23,700			21,880			68,811			61,080
Total operating expenses	82,527			96,207			248,901			265,189
Operating income (loss):
Nature’s Sunshine Products:
United States	2,694			2,343			9,823			9,804
International	3,449			(10,092		)	11,327			(6,191		)
	6,143			(7,749		)	21,150			3,613
Synergy WorldWide	2,562			2,644			7,040			6,955
Total operating income (loss)	8,705			(5,105		)	28,190			10,568
Other income (expense), net	(214		)	1,204			(159		)	1,049
Income (loss) before provision for income taxes	$	8,491		$	(3,901	)	$	28,031		$	11,617

NSP International’s operating loss of $10,092 and $6,191 for the three and nine months ended September 30, 2011, includes $14,750 of contract termination costs related to the Company’s arbitration settlement with NutriPlus LLC (described further in Note 1, Basis of Presentation).

From an individual country perspective, only the United States comprises 10 percent or more of consolidated net sales revenue for the three and nine-month periods ended September 30, 2012 and 2011 as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Net sales revenue:
United States	$	38,243	$	38,885	$	118,390	$	120,868
Other	52,989		52,217		158,701		154,889
	$	91,232	$	91,102	$	277,091	$	275,757

Revenue generated by each of the Company’s product lines is set forth below:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
NSP United States:
Herbal products	$	17,809	$	17,441	$	56,010	$	55,344
Vitamin, mineral and other nutritional supplements	14,296		14,280		43,061		43,204
Personal care products	970		1,011		2,976		3,328
Other products	620		787		2,006		3,185
	33,695		33,519		104,053		105,061
NSP International:
Herbal products	$	16,913	$	18,502	$	52,188	$	56,244
Vitamin, mineral and other nutritional supplements	12,037		12,053		37,191		37,631
Personal care products	1,944		2,128		6,660		7,473
Other products	381		376		1,148		1,313
	31,275		33,059		97,187		102,661
Synergy WorldWide:
Herbal products	$	10,005	$	9,797	$	29,982	$	27,428
Vitamin, mineral and other nutritional supplements	14,510		12,699		40,575		34,668
Personal care products	1,394		1,378		4,020		4,230
Other products	353		650		1,274		1,709
	26,262		24,524		75,851		68,035
	$	91,232	$	91,102	$	277,091	$	275,757

From an individual country perspective, only the United States and Venezuela comprise 10 percent or more of consolidated property, plant and equipment as follows:

	September 30, 2012		December 31, 2011
Property, plant and equipment:
United States	$	20,951	$	18,119
Venezuela	3,636		3,939
Other	3,388		3,079
Total property, plant and equipment	$	27,975	$	25,137

XML

Net Income Per Share

9 Months Ended

Sep. 30, 2012

Net Income Per Share

Net Income Per Share

(6)Net Income Per Share

Basic net income per common share (“Basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.

The following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September 30, 2012 and 2011:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2012		2011			2012		2011
Net income (loss)	$	6,370	$	(2,256	)	$	20,884	$	9,980
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Basic net income per common share:
Net income (loss) per common share	$	0.41	$	(0.14	)	$	1.34	$	0.64
Diluted weighted average shares outstanding
Basic weighted average shares outstanding	15,628		15,562			15,603		15,544
Weighted average stock grants outstanding	343		—			314		130
Diluted weighted average shares outstanding	15,971		15,562			15,917		15,674
Diluted net income per common share:
Net income (loss) per common share	$	0.40	$	(0.14	)	$	1.31	$	0.64
Potentially dilutive shares excluded from diluted per share amounts:
Stock options	96		—			96		661
Potentially anti-dilutive shares excluded from diluted per share amounts:
Stock options	167		1,379			249		202

Potentially dilutive shares excluded from diluted per share amounts include performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved. Potentially anti-dilutive shares excluded from diluted per share amounts include both time-based stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted average share price during the period and shares that would be anti-dilutive to the computation of dilutive net income per share for the three and nine months ended September 30, 2012 and 2011.

XML

Capital Transactions

9 Months Ended

Sep. 30, 2012

Capital Transactions

Capital Transactions

(7)Capital Transactions

Dividends

The declaration of future dividends is subject to the discretion of the Company’s Board of Directors and will depend upon various factors, including the Company’s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by its Board of Directors.

On May 7, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on May 29, 2012 to shareholders of record on May 18, 2012. On August 1, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on August 23, 2012 to shareholders of record on August 13, 2012.

Share-based Compensation

During the nine-month period ended September 30, 2012, the Company’s shareholders adopted and approved the Nature’s Sunshine Products, Inc. 2012 Stock Incentive Plan (the “2012 Incentive Plan”).  The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.  The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500 shares of the Company’s common stock were authorized for the granting of awards under the 2012 Incentive Plan. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.

The Company also maintains a stock incentive plan, which was approved by shareholders in 2009 (the “2009 Incentive Plan”). The 2009 Incentive Plan also provided for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.  Under the 2012 Incentive Plan, any shares subject to award, or awards forfeited or reacquired by the Company issued under the 2009 Incentive Plan are available for award up to a maximum of 400 shares.

The Company also maintained a stock option plan, which was approved by shareholders in 1995 and expired in 2005 (“the 1995 Stock Plan”). The 1995 Stock Plan provided for the granting or awarding of certain nonqualified stock options to officers, directors and other employees. The term, not to exceed 10 years, and the vesting and exercise period of each stock option awarded under the 1995 Stock Plan were determined by the Company’s Board of Directors.

Stock option activity for the nine months ended September 30, 2012 is as follows:

	Number of Shares		Weighted Average Exercise Price Per Share
Options outstanding at December 31, 2011	1,374		$	9.88
Granted	681		15.11
Expired	(6	)	8.59
Exercised	(191	)	10.34
Options outstanding at September 30, 2012	1,858		11.75

The Company’s outstanding stock options include time-based stock options which vest over differing periods ranging from the date of issuance up to 48 months from the option grant date, performance-based stock options which vest upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options, and performance-based stock options which vest upon achieving cumulative annual net sales revenue growth targets over a rolling two-year period subject to the Company maintaining at least an eight percent operating income margin during the applicable period.

During the nine-month period ended September 30, 2012, the Company issued time-based options to purchase 217 shares of common stock under the 2009 Incentive Plan to the Company’s new senior executives. These options were issued with a weighted average exercise price of $15.65 per share and a weighted average grant date fair value of $7.66 per share. All of the options issued have an option termination date of ten years from the option grant date.

Also, during the nine-month period ended September 30, 2012, the Company issued options to purchase 464 shares of common stock under the 2012 Incentive Plan to the Company’s executive officers and other employees, which are composed of both time-based stock options and net sales revenue performance-based stock options. These options were issued with a weighted average exercise price of $14.86 per share and a weighted average grant date fair value of $7.01 per share. All of the options issued have an option termination date of ten years from the option grant date.

The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted average assumptions for the nine month period ended September 30, 2012:

	2012
Expected life (in years)	4.0 to 6.0
Risk-free interest rate	0.3 to 0.9
Expected volatility	58.5 to 66.0
Dividend yield	0.0 to 1.3

Expected option lives and volatilities are based on historical data of the Company. The risk free interest rate is calculated as the average U.S. Treasury obligation rate that corresponds with the option life.

Share-based compensation expense from time-based stock options for the three-month periods ended September 30, 2012 and 2011 was approximately $630 and $166, respectively; the related tax benefit was approximately $246 and $66, respectively. Share-based compensation expense from time-based stock options for the nine-month periods ended September 30, 2012 and 2011 was approximately $1,299 and $390, respectively; the related tax benefit was approximately $513 and $156, respectively. As of September 30, 2012 and December 31, 2011, the unrecognized share-based compensation expense related to the grants described above was $3,285 and $607, respectively. As of September 30, 2012, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 1.9 years.

Share-based compensation expense from operating income performance-based stock options for the three-month periods ended September 30, 2012 and 2011was approximately $0 and $607, respectively; the related tax benefit was approximately $0 and $240, respectively. Shared-based compensation expense from operating income performance-based stock options for the nine-month periods ended September 30, 2012 and 2011was approximately $652 and $1,527, respectively; the related tax benefit was approximately $255 and $603, respectively. As of September 30, 2012 and December 31, 2011, the unrecognized share-based compensation expense related to these options was approximately $0 and $652, respectively. As of September 30, 2012, there is no remaining compensation expense to be recognized for the operating income performance-based stock options.

The Company has not recognized any share-based compensation expense related to the net sales revenue performance-based stock options for the three and nine-month periods ended September 30, 2012.  Should the Company attain all of the net sales revenue metrics related to the net sales revenue performance-based stock option grants, the Company could recognize up to $700 of potential share-based compensation expense.

At September 30, 2012, the aggregate intrinsic value of all outstanding stock options to purchase 1,858 shares of common stock, exercisable stock options to purchase 1,061 shares of common stock and stock options to purchase 660 shares of common stock that are expected to vest (net of expected forfeitures) was $8,367, $7,213 and $1,085, respectively. At December 31, 2011, the aggregate intrinsic value of outstanding options to purchase 1,374 shares of common stock, the exercisable options to purchase 772 shares of common stock, and options to purchase 602 shares of common stock expected to vest (net of expected forfeitures) was $7,757, $4,819 and $2,732, respectively.

Restricted stock unit activity for the nine months ended September 30, 2012 is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Units outstanding at December 31, 2011	—	$	—
Granted	18	12.07
Vested	—	—
Forfeited	—	—
Units outstanding at September 30, 2012	18	12.07

During the nine-month period ended September 30, 2012, the Company issued 18 restricted stock units (RSUs) of common stock under the 2012 Incentive Plan to the Board of Directors. The RSUs were issued with a weighted average grant date fair value of $12.07 per share and vest over a one year period from the grant date.

RSUs are valued at the market value on the date of grant.  Due to post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. The Finnerty Model proposes to estimate a discount for lack of marketability such as transfer restrictions by using an option pricing theory. This model has gained recognition through its ability to address the magnitude of the discount by considering the volatility of a company’s stock price and the length of restriction. The concept underpinning the Finnerty Model is that restricted stock cannot be sold over a certain period of time.

Share-based compensation expense from RSUs for the three and nine-month periods ended September 30, 2012 was approximately $50 and the related tax benefit was approximately $20. As of September 30, 2012, the unrecognized share-based compensation expense related to the grants described above was $173. As of September 30, 2012, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.7 years.

XML

Income Taxes

9 Months Ended

Sep. 30, 2012

Income Taxes

Income Taxes

(9)       Income Taxes

Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the periods in which they occur. For the three months ended September 30, 2012 and 2011, the Company’s provision (benefit) for income taxes, as a percentage of income (loss) before income taxes was 25.0 percent and (42.2) percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.  For the nine months ended September 30, 2012 and 2011, the Company’s provision for income taxes, as a percentage of income before income taxes was 25.5 percent and 14.1 percent, respectively, compared with a U.S. federal statutory rate of 35.0 percent.

The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.8 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.2 percent).

The difference between the effective tax rate and the U.S. federal statutory rate for the three months ended September 30, 2011 was primarily attributed to the pretax loss related to contract termination costs, in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-3.9 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2012 was primarily attributed to a domestic valuation allowance release related to the utilization of foreign tax credits (-6.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and adjustments to foreign valuation allowances (-4.0 percent).

The difference between the effective tax rate and the U.S. federal statutory tax rate for the nine months ended September 30, 2011 was primarily attributed to contract termination costs (-9.5 percent), in addition to net favorable foreign items related to foreign tax rate differences, the impact of unremitted earnings, and a favorable inflation adjustment related to Venezuela (-11.5 percent).

The Company’s U.S. federal income tax returns for 2003 through 2005, and 2009 through 2011 are open to examination for federal tax purposes. The Company has several foreign tax jurisdictions that have open tax years from 2004 through 2011. The Internal Revenue Service (“IRS”) is currently conducting an audit of the Company’s U.S. federal income tax returns for the 2009 and 2010 tax years.

In October 2009, the IRS issued an examination report formally proposing adjustments with respect to the 2003 through 2005 taxable years, which primarily related to the prices that were charged in intra-group transfers of property and the disallowance of related deductions. The Company challenged the IRS proposals, and took the matter before the Office of Appeals of the Internal Revenue Service.  A settlement was reached with IRS Appeals and a proposed settlement agreement was signed by NSP in January 2012. As of September 30, 2012, the Company has made all required payments related to this matter and, absent further comment from the IRS, the examination period for the 2003 through 2005 taxable years will close on December 31, 2012.

During 2011, the IRS issued an examination report formally proposing adjustments with respect to the 2006 through 2008 taxable years.  As with the previous examination cycle discussed above, the adjustments related primarily to the prices that were charged in intra-group transfers of property and the disallowance of related deductions.  The Company reached a settlement of the issues with the IRS examination team and an agreement was signed by the Company in January 2012.  On March 7, 2012, the Company received a letter from the IRS examination team stating that they accepted the examination report and do not plan to make additional changes. The Company has made all required payments related to this matter and the examination period for the 2006 through 2008 taxable years are now closed.

As of September 30, 2012, the Company had accrued $9,772 related to unrecognized tax positions compared with $10,426 as of December 31, 2011. This net decrease was primarily attributed to the expiration of the statute of limitations on certain liabilities in various foreign jurisdictions.

Changes to the effective rate due to dividends received from foreign subsidiaries, impact of foreign tax credits and the unremitted earnings calculation are expected to be recurring; however, depending on various factors, the changes may be favorable or unfavorable in a particular period. The Company’s aggregate consolidated effective tax rate will typically reflect differences between the lower statutory rates in foreign markets compared to the U.S. statutory rate of 35 percent. Given the large number of jurisdictions in which the Company does business and the number of factors that can impact effective tax rates in any given year, the consolidated effective rate is likely to reflect relatively significant fluctuations from year-to-year.

Although the Company believes its estimates related to its unrecognized tax benefits are reasonable, the Company can provide no assurances that the final tax outcome of these matters will not be different from that which it has reflected in its historical income tax provisions and accruals. Any difference in the final tax outcome of these matters could have a material impact on the Company’s income tax provision and operating results in the periods in which the Company makes such determination.

XML

Capital Transactions (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	1 Months Ended		3 Months Ended	9 Months Ended			9 Months Ended		3 Months Ended		9 Months Ended			9 Months Ended	3 Months Ended		9 Months Ended			9 Months Ended			3 Months Ended	9 Months Ended		9 Months Ended			9 Months Ended	12 Months Ended
	Aug. 31, 2012	May 31, 2012	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2012 Stock options	Dec. 31, 2011 Stock options	Sep. 30, 2012 Stock options Minimum	Sep. 30, 2012 Stock options Maximum	Sep. 30, 2012 Time-based stock options	Sep. 30, 2011 Time-based stock options	Sep. 30, 2012 Time-based stock options	Sep. 30, 2011 Time-based stock options	Dec. 31, 2011 Time-based stock options	Sep. 30, 2012 Time-based stock options Maximum	Sep. 30, 2012 Operating income performance-based stock options	Sep. 30, 2011 Operating income performance-based stock options	Sep. 30, 2012 Operating income performance-based stock options	Sep. 30, 2011 Operating income performance-based stock options	Dec. 31, 2011 Operating income performance-based stock options	Sep. 30, 2012 Net sales revenue performance-based stock options	Sep. 30, 2012 Net sales revenue performance-based stock options Minimum	Sep. 30, 2012 Net sales revenue performance-based stock options Maximum	Sep. 30, 2012 Restricted stock unit	Sep. 30, 2012 Restricted stock unit	Sep. 30, 2012 2009 Incentive Plan Maximum	Sep. 30, 2012 2009 Incentive Plan Stock options	Sep. 30, 2012 2009 Incentive Plan Time-based stock options	Sep. 30, 2012 2012 Incentive Plan	Sep. 30, 2012 2012 Incentive Plan Stock options	Dec. 31, 1995 1995 Stock Plan Maximum
Dividends [Abstract]
Cash Dividend per common share (in dollars per share)	$ 0.05	$ 0.05	$ 0.05	$ 0.10
Dividend paid	$ 780	$ 780
Share-based Compensation
Number of shares authorized																									400			1,500
Expiration period																										10 years			10 years	10 years
Number of shares
Options outstanding at the beginning of the period (in shares)					1,374
Granted (in shares)					681																						217		464
Expired (in shares)					(6)
Exercised (in shares)					(191)
Options outstanding at the end of the period (in shares)					1,858
Weighted Average Exercise Price Per Share
Options outstanding at the beginning of the period (in dollars per share)					$ 9.88
Granted (in dollars per share)					$ 15.11																					$ 15.65			$ 14.86
Expired (in dollars per share)					$ 8.59
Exercised (in dollars per share)					$ 10.34
Options outstanding at the end of the period (in dollars per share)					$ 11.75
Share-based compensation, additional disclosures
Vesting period														48 months										1 year
Operating income margin, one (as a percent)																	6.00%
Operating income margin, two (as a percent)																	8.00%				8.00%
Operating income margin, three (as a percent)																	10.00%
Period of time during which operating income margins must be achieved in order to vest in performance based stock options																	12 months
Consecutive period of time used to assess operating income margins which determine vesting											15 months
Period of cumulative net sales revenue growth																				2 years
Weighted-average grant date fair value (in dollars per share)																										$ 7.66			$ 7.01
Weighted-average assumptions used to calculate fair value of options granted
Expected life							4 years	6 years
Risk-free interest rate (as a percent)							0.30%	0.90%
Expected volatility (as a percent)							58.50%	66.00%
Dividend yield (as a percent)							0.00%	1.30%
Share-based compensation, related information
Share-based compensation expense									630	166	1,299	390			0	607	652	1,527					50	50
Related tax benefits									246	66	513	156			0	240	255	603					20	20
Unrecognized share-based compensation expense									3,285		3,285		607		0		0		652				173	173
Expense expected to be recognized over a weighted-average period											1 year 10 months 24 days													8 months 12 days
Potential share-based compensation expense.																						700
Exercisable (in shares)					1,061	772
Expected to vest (net of expected forfeitures) (in shares)					660	602
Aggregate Intrinsic value, outstanding					8,367	7,757
Aggregate Intrinsic value, exercisable					7,213	4,819
Aggregate Intrinsic value, expected to vest					$ 1,085	$ 2,732
Number of Shares
Granted (in shares)																								18
Units outstanding at the end of the period (in shares)																							18	18
Weighted Average Grant Date Fair Value
Granted (in dollars per share)																								$ 12.07
Units outstanding at the end of the period (in dollars per share)																							$ 12.07	$ 12.07

XML

Investments (Tables)

9 Months Ended

Sep. 30, 2012

Investments

Schedule of amortized cost and estimated fair values of available-for-sale securities by investment category

As of September 30, 2012	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	709	$	36	$	—		$	745
U.S. government securities funds	990		—		(4		)	986
Equity securities	227		240		(6		)	461
Total short-term investment securities	$	1,926	$	276	$	(10	)	$	2,192

As of December 31, 2011	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Municipal obligations	$	1,158	$	51	$	—		$	1,209
U.S. government securities funds	988		—		(5		)	983
Short-term deposits	3,104		—		—			3,104
Equity securities	227		159		(5		)	381
Total short-term investment securities	$	5,477	$	210	$	(10	)	$	5,677

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2012

Fair Value Measurements

Schedule of the entity's hierarchy for assets measured at fair value on a recurring basis

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of September 30, 2012:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	745	$	—	$	745
U.S. government security funds	986		—		—		986
Equity securities	461		—		—		461
Investment securities	1,317		—		—		1,317
Total assets measured at fair value on a recurring basis	$	2,764	$	745	$	—	$	3,509

The following table presents the Company’s hierarchy for its assets measured at fair value on a recurring basis as of December 31, 2011:

	Level 1		Level 2		Level 3
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs		Total
Investments available for sale
Municipal obligations	$	—	$	1,209	$	—	$	1,209
U.S. government security funds	983		—		—		983
Short-term deposits	—		3,104		—		3,104
Equity securities	381		—		—		381
Investment securities	1,429		—		—		1,429
Total assets measured at fair value on a recurring basis	$	2,793	$	4,313	$	—	$	7,106

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales revenue, rebate portion of volume incentives	$ 10,460	$ 10,877	$ 32,746	$ 33,815

XML

Intangible Assets

9 Months Ended

Sep. 30, 2012

Intangible Assets

Intangible Assets

(3)Intangible Assets

At September 30, 2012 and December 31, 2011, intangibles for product formulations had a gross carrying amount of $1,763 and $1,763, accumulated amortization of $723 and $612, and a net amount of $1,040 and $1,151, respectively. The estimated useful lives of the product formulations range from 9 to 15 years.

Amortization expense for intangible assets for the three months ended September 30, 2012 and 2011 was $37 and $37, respectively. Amortization expense for intangible assets for the nine months ended September 30, 2012 and 2011 was $111 and $111, respectively. Estimated amortization expense for each of the next five fiscal years is $149.

XML

Basis of Presentation (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended
	Jul. 31, 2011	Sep. 30, 2011	Sep. 30, 2011	Jul. 08, 2011	Sep. 30, 2012 Belarusian subsidiary	Sep. 30, 2012 Belarusian subsidiary
Classification of Belarus as a Highly Inflationary Economy and Devaluation of Its Currency
Net sales revenue (as a percent)					1.60%	1.50%
Contract Termination Costs
Settlement amount	$ 21,700
Previously accrued but unpaid royalties				6,950
Contract termination costs	$ 14,750	$ 14,750	$ 14,750

XML

Fair Value Measurements (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Fair value measurements
Investments available for sale	$ 2,192	$ 5,677
Municipal obligations
Fair value measurements
Investments available for sale	745	1,209
U.S. government security funds
Fair value measurements
Investments available for sale	986	983
Short-term deposits
Fair value measurements
Investments available for sale		3,104
Equity securities
Fair value measurements
Investments available for sale	461	381
Recurring basis | Level 1 - Quoted Prices in Active Markets for Identical Assets
Fair value measurements
Investment securities	1,317	1,429
Total assets measured at fair value on a recurring basis	2,764	2,793
Recurring basis | Level 1 - Quoted Prices in Active Markets for Identical Assets | U.S. government security funds
Fair value measurements
Investments available for sale	986	983
Recurring basis | Level 1 - Quoted Prices in Active Markets for Identical Assets | Equity securities
Fair value measurements
Investments available for sale	461	381
Recurring basis | Level 2 - Significant Other Observable Inputs
Fair value measurements
Total assets measured at fair value on a recurring basis	745	4,313
Recurring basis | Level 2 - Significant Other Observable Inputs | Municipal obligations
Fair value measurements
Investments available for sale	745	1,209
Recurring basis | Level 2 - Significant Other Observable Inputs | Short-term deposits
Fair value measurements
Investments available for sale		3,104
Recurring basis | Total
Fair value measurements
Investment securities	1,317	1,429
Total assets measured at fair value on a recurring basis	3,509	7,106
Recurring basis | Total | Municipal obligations
Fair value measurements
Investments available for sale	745	1,209
Recurring basis | Total | U.S. government security funds
Fair value measurements
Investments available for sale	986	983
Recurring basis | Total | Short-term deposits
Fair value measurements
Investments available for sale		3,104
Recurring basis | Total | Equity securities
Fair value measurements
Investments available for sale	$ 461	$ 381

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2012

Inventories

Schedule of inventories

	September 30,		December 31,
	2012		2011
Raw Materials	$	13,814	$	12,992
Work in Progress	931		1,230
Finished Goods	28,910		27,389
	$	43,655	$	41,611